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1. INTRODUCTION: TIMING Of ORAl 
CANCER DIAGNOSIS: IMPlICATIONS fOR 
PROGNOSIS AND SURvIvAl
Oral cancer has become a global health problem (Parkin, 2005; gillison, 2007) 
and its increasing incidence and mortality rates are particularly relevant in cer-
tain parts of Europe (France, Hungary, Spain and Croatia), Brazil, and South-
Eastern Asia (Sri Lanka, Pakistan, Bangladesh and India) (Warnakulasuriya, 
2009). These geographical variations seem to reflect disparities in tobacco, 
areca nut and alcohol consumption (Warnakulasuriya, 2009). Worldwide, 
oral cancer has one of the lowest survival rates that remains unaltered de-
spite recent therapeutic advances. young adults seem to be growingly affected 
by tongue cancer in Brazil, several European countries and USA (Llewellyn, 
2004). However, current reports describe a trend –more marked for tongue 
carcinomas- towards improved survival at each stage and at all ages but ≥75 
years (Pulte, 2010). 
Search for prognostic markers for oral cancer has been extensive and 
thorough with diverse results: age, gender, immunological or nutritional sta-
tus, size and location of the tumour, disease stage, nodal status, oncogene ex-
pression, proliferation markers, or DNA content have been allocated indepen-
dent prognostic value (Johnson, 1996); but tumour stage at diagnosis remains 
the most important prognostic maker for oral squamous cell carcionoma 
(garzino-Demo, 2006). Unfortunately, almost half of the oral neoplasms are 
diagnosed at stages III or IV, with 5.year survival rates ranging from 20% to 
50% depending upon tumour sites (Holmes, 2003; Brandizzi, 2005).
Early detection is widely recognised as the cornerstone to reduce diag-
nostic delay and, thus, to improve survival (De Faria , 2003; McDowell, 2006). 
However, this term (early detection) is not free from confusion as can be un-
derstood either as “a relative small tumour in size at the time of detection” or 
as “short time interval since cancer onset to diagnosis” (diagnostic delay) (van 
der Waal, 2011).
1.1. Early detection. Diagnosis of small-size oral carcinoma
Tumour size influences therapy and prognosis of oral cancer. Diagnosis of 
larger oral carcinomas has been linked to an increased risk of neck-node me-
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tastases and poor survival (Woolgar, 1999). Lately, this variable (plain clinical 
or pathological tumour size) has been replaced by tumour thickness or depth 
of invasion as more significant prognostic factors (gonzalez-Moles, 2002; O-
charoenrat, 2003). Moreover, tumour thickness has proved independent pre-
dictive value for subclinical node metastases, local recurrence and survival 
(Po Wing yuen, 2002). Accordingly, a critical thickness of 4 mm has been pro-
posed, above which the risk for metastases is 4 times the risk of tumours with 
minor invasion depth (Ambrosch, 1995). generally speaking, a small-size tu-
mour should present a diameter inferior than 2 cm, less than 4 mm of inva-
sion depth and usually asymptomatic (Woolgar, 2006). Thus, clinicians are 
recommended to be watchful on the signs of potentially malignant lesions or 
early stage cancers in all patients, but particularly on heavy smokers and alco-
hol consumers. These signs include indurations, bleeding, exophytic growths 
larger than 1 mm, chronic ulcerations with irregular, dirty or spotty appear-
ance in lesions that do not disappear after the hypothetical causal agents have 
been removed, together with texture changes or granulation on the surface of 
the lesion. Moreover, keeping in mind that persistent erythroplastic lesions 
are the most frequent clinical presentation of early carcinomas (Mashberg, 
1977; Mashberg, 1988; Bouquot, 1995) (Fig 1) along with erythro-leukoplastic 
(23%) and leukoplastic lesions (21%) may ease an early diagnosis of oral can-
cer (Mashberg, 1995).
Fig. 1. Erythroplastic oral squamous cell carcinoma.
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1.2. Diagnostic delay in oral cancer. Concept
The concept of diagnostic delay would comprise the time since first sign or 
symptom to definitive diagnosis. This fairly clear concept has been studied 
from different point of views with heterogeneous criteria (Allison, 1998a; Al-
lison, 1998b; Allison, 1998c), resulting in categorisations that include: “patient 
delay”: the period between the patient first noticing a symptom and the first 
consultation with a health professional about the symptom; and “professional 
delay”: the period from patient’s first consultation with a clinician to the defin-
itive pathological diagnosis”. This categorisation can be broken down further 
to include the “delay by patients”: time until consultation due to inaccessibil-
ity to the healthcare provider (Allison, 1998a; Allison, 1998b; Allison, 1998c; 
Onizawa, 2003) –which is not always due to the patients-. To overcome this 
ambiguity, the term “scheduling delay” (period between the patient making 
an appointment and actually seeing a healthcare professional) was introduced 
(Diz-Dios, 2005) (Figure 2).
Fig. 2. Types of diagnostic delay in oral cancer.
Despite these efforts, to date there is no consensus on a time-point beyond 
which a cancer diagnosis can be considered delayed. Several research groups 
have used the mean or the median of the time distribution to categorise diag-
nostic delay (Andersen, 1995; Pitiphat, 2002; Carvalho, 2002; gorsky, 1995), 
the latter being more frequent as it is not affected by the extreme values of 
distributions that usually show very wide ranges. Other authors choose an 
arbitrary time-point (more than thirty days) to discriminate between delayed 
and non-delayed cases (Allison, 1998a; Allison, 1998b; Allison, 1998c; Brou-
ha, 2005), in order to allow time for the patient to identify the symptoms, seek 
consultation, for a follow up of 7-10 days and a second consultation and bi-
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opsy, and, finally for the pathologist to report the results back to the clinician 
(gorsky, 1995).
Other criteria include a first stage: since the first symptom until de first 
contact with the clinician; a second stage: since the first visit until a referral 
letter is written; a third stage: since the patient gets the referral letter until the 
first consultation at a specialised service; and a 4th stage, since the first consul-
tation to a specialist until a definitive diagnosis is reached (Onizawa, 2003). As 
can be inferred, his approach introduces some degree of complexity and limits 
the external validity of the studies performed under this scheme.
Regardless of the importance of this topic, it is somehow surprising the 
limited number of reports dealing with the influence of diagnostic delay in 
head and neck carcinomas retrievable from scientific databases, particularly 
when compared to melanoma or colorectal, breast, and bladder carcinomas.
1.3. Causes of oral cancer diagnostic delay
The proportion of patients receiving a delayed definitive diagnosis of oral 
cancer remains high worldwide, with wide variations in the values reported: 
in greece more than a half of oral cancer patients are diagnosed with delays 
longer than 3 weeks (Pitiphat, 2002), whereas Dutch and Spanish patients 
are diagnosed with an average delay of 1.5 months (kowalsky, 1994; Seoane, 
2006); series published from Canada, Italy, Denmark or Israel report medians 
of diagnostic delays ranging from 3 to four months (Allison, 1998a; Allison, 
1998b; Allison, 1998c; Wildt, 1995; gorsky, 1995 ).
Undoubtedly, there are potential factors responsible for late diagnosis of 
oral cancer: on the one hand, psychosocial factors related to the patient may 
well condition the perception of the cancer symptoms by the individual and 
lead him/her to erroneous behavioural responses that may adversely affect 
his/her demands and access to care. This may explain why the use of tradition-
al herbal medication before visiting a healthcare professional is recognised as 
a significant independent predictor for patient delay in Thailand (kerdpon, 
2001a; kerdpon, 2001b).
On the other hand, the accessibility (ability to obtain services based on 
oral health needs) can be limited by financial, structural and personal bar-
riers (beliefs, language) and thus decisively conditioning the timing of oral 
cancer diagnosis (Seoane, 2010). Disparities in access to oral health services 
across Europe and USA are well known, particularly for low-income popu-
lations (uninsured, migrant, homeless, etc). Ethno regional differences have 
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also been identified in terms of incidence and mortality rates of oral cancer, 
which may result from the variation in the access to oral care but also from the 
different exposition to risk factors or from the limited resources in detection 
and prevention methods available to these individuals.
The causes of diagnostic delay related to the clinician are particularly in-
teresting, and can be basically due to not to practice a full clinical examina-
tion (Bruun, 1976), the presence of unspecific or banal clinical signs (Bruun, 
1976), low index of suspicion and lack of familiarity and experience with the 
disease (guggenheimer, 1989). Co-morbidity has also been suggested (Alli-
son, 1998a; Allison, 1998b; Allison, 1998c), as clinicians in these situations 
tend to focus their attention on the existing disorders.
Lack of oral cancer knowledge has also been described to influence de-
lays in referral and treatment (Colella, 2008; Seoane 2010), and this situation 
has been detected internationally as a worrying lack of knowledge on diagnos-
tic procedures, main locations of oral cancer (Alonge, 2003) and on leuko- or 
erythroplakia-like carcinomas as primary oral cancer lesions, as well as on the 
effects of vegetable intake on the incidence of oral cancer. Conversely, facts 
like squamous cell carcinoma being the most common histopathologial type 
or oral cancer, criteria for referral of patients with suspicious lesions, that early 
detection improves the 5-year survival rate and that tobacco and alcohol are 
risk factors for oral cancer (Seoane, 2010) are well known by the healthcare 
professionals.
In short, diagnostic delay is a complex concept conditioned by tumour 
biology, patient behaviour, clinician awareness and attitudes, as well as by the 
healthcare system performace.
1.4. Other factors related to late stage diagnosis of oral squamous cell 
carcinoma.
Although recognition of predictors for advanced-stage diagnosis could per-
mit the implementation of strategies for increasing the number of oral carci-
nomas diagnosed at an early stage, there is no much information on this issue.
The most frequently studied variables (age, gender, and tobacco and al-
cohol intake) are not linked to late-stage diagnosis, as were not previously as-
sociated to professional or patient-related delays (Boing, 2010; guggenheimer 
1989). Neither precancerous lesions connected to the tumour seem to modify 
the spread of the disease at diagnosis, even when proliferative verrucous leu-
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koplakia or the presence of mild to moderate epithelial dysplasia at the mar-
gins of a surgically removed oral squamous cell carcinoma carries a significant 
risk of local recurrence and modifies the prognosis of the disorder (Thomsom, 
2007).
Ulcerated-type oral squamous cell carcinomas are usually diagnosed at 
stages III or IV (Jaulerry, 1985) (Figure 3). Although the predictive value of 
the clinical appearance of the primary lesion remains controversial, it is ac-
cepted that ulcerated lesions imply poorer survival rates (Jaulerry, 1985).
Fig. 3. Ulcerated-type tongue squamous cell carcinoma.
The site of the primary lesion has been also linked either to delayed diagnosis 
or diagnosis at advanced stages (Brouha, 2005): tongue, buccal mucosa and lip 
carcinomas seem to be diagnosed at earlier stages (gorsky, 1995) than floor 
of the mouth and retromolar trigone neoplasms; whereas palate or gingival 
tumours showed contradictory results (gorsky, 1995). Accordingly, the floor 
of the mouth, gingivae and retromolar trigone have recently been identified 
as independent prognostic factors for late-stage diagnosis, which may well be 
explained by the fact that patient’s self-perception and self-exploration abili-
ties are conditioned by the site of the tumour (Andersen, 1995); the presence 
of the gingivae within this group would be due to the association of gingival 
locations to advanced stage at diagnosis (late diagnosis) caused by the early 
invasion of the nearby bone (T4 primary tumour) (Seoane, 2006).
Late diagnosis of neoplasms, particularly in oral cancer, has been con-
ventionally ascribed to delays in reaching a diagnosis, as patients at advanced 
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tumour stages are more likely to have experienced longer patient and pro-
fessional delays than those diagnosed at earlier stages (Sargeran, 2009). Sur-
prisingly, there is an evident lack of sound scientific evidence supporting this 
traditional association between diagnostic delay and disease extension (III-IV 
TNM stages) (gomez, 2009; gomez, 2010).
The biological behaviour of the tumour has also been investigated as 
an hypothetical predictor for a late-stage diagnosis, with positive results, as 
poorly differentiation of a tumour (biologically more aggressive) proved to be 
an independent risk factor for diagnosis at stages III and IV, which may sug-
gest that the TNM stage of a tumour when diagnosed could be affected more 
by the biology of the cancer (degree of differentiation) than by a delay in the 
diagnosis. 
1.5. Relationships between diagnostic delay in primary oral cancer 
and disease extension.
Tumour size and nodal status seem to correlate well with tumour growth 
chronology in oral cancer (Spiro, 1986; Brown, 1989; Parker, 1996). This par-
adigm leaded to investigations on the feasibility that diagnostic delay con-
tributes to the spread of the disease. Despite this theory could be proved for 
certain tumours (Erwenne, 1989; Porta , 1991; Faccione, 1993), no definitive 
conclusions could be drawn for oral cancer, where disagreements between the 
groups who discard an association (Allison et al, 1998; kantola et al, 2001; 
kerdpon et al, 2001b) and those who endorse it (O’Sullivan, 2001; Brouha et 
al, 2005b, gomez et al., 2009) are evident.
The paper by guggenheimer et al (1989) was one of the first in consid-
ering this hypothetical relationship in a mixed sample of 149 oral and pha-
ryngeal cancers and failed to identify an association even after considering 
patient and professional delays separately. From then on, this has been a com-
mon conclusion in the literature (Jovanovic et al, 1992; Amir et al, 1999; Hol-
lows et al, 2000; kerdpon et al, 2001a; kerdpon et al 2001b) until 1994, when 
kowalski et al. significantly related professional delay and tumour stage, but 
not between overall delay and spread of the disease, which may suggest the 
relevance of memory bias in this particular type of research.
The control of biases is a challenging issue for researchers in this field. The 
consideration of patient survival as the research outcome and the use of multi-
variate analysis to adjust for confounding factors (Wildt et al, 1995) meant an 
22 INTRODUCTION
improvement in the design of these studies but the sought association could 
not still be identified for oral cancer (Wildt et al , 1995) or for mixed samples 
of head and neck carcinomas (gorsky & Dyan, 1995). Research designs were 
further improved by the combination of data collection methods to include 
prospective and retrospective data for reducing memory bias: Mcgurk et al 
(2005) gathered a sample of 613 cases over 40 years and failed to unveil a 
relationship between delay in diagnosis and tumour stage but they used an 
arbitrary time point of three months to distinguish between delayed and non-
delayed cases in their mixed sample of head and neck cancers that, combined 
with a vague definition of diagnostic delay, compromise their conclusions.
The composition of the study sample may be relevant, since Scott et al 
(2005) found no relationship between diagnostic delay and tumour stage, but 
discovered a trend in this direction for certain oral sites. Carvalho et al (2002) 
somehow confirmed this trend in their series of 676 head and neck squamous 
cell carcinomas when observed that laryngeal and hypopharyngeal cancers 
were more prone to be diagnosed at advanced stages than lip, oral and oro-
pharyngeal neoplasms. Additional light in this course was provided by Allison 
et al (1998c) who demonstrated that patients with upper aerodigestive tract 
carcinomas with professional delays longer than 1 month had an increased 
risk to be diagnosed at late stage.
When dealing with diagnostic delay, the beginning of any study is, un-
avoidably, the recognition of the signs and symptoms by the patient, and this 
recognition is undoubtedly affected by his/her psychosocial characteristics. 
The first group in considering these variables was that of kumar et al (2001) 
who identified a significant relationship between overall diagnostic delay and 
tumour stage in their sample of 79 patients. Similar findings were reported by 
Pitiphat et al (2002) from a case-control study, demonstrating that the length 
of diagnostic delay was significantly greater in patients with advanced tumour 
stages (TNM stage IV).
There is no sound scientific evidence supporting an association between 
diagnostic delay in oral cancer, extension of the disease diagnosed at advancer 
stages (TNM III-IV) and lower survival rates. However, this fact is probably 
due to methodological flaws in the published reports to date (Allison, 1998a; 
Allison, 1998b; Allison, 1998c). These reports use different conceptions of di-
agnostic delay and are thus liable to misclassifications; use retrospective de-
signs without strategies to diminishing patients’ memory bias and often break 
down diagnostic delay classifications to groups with insufficient sample size. 
Moreover, the study of samples with heterogeneous cancer sites introduce 
confounding factors in the analysis, as the patient’s self-perception and self- 
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exploration abilities depend on the site of the tumour (Allison et al, 1998a; 
Tromp et al., 2005; Wildt et al, 1995; O’Sullivan, 2001). For example, gingival 
locations are associated with advanced stages at diagnosis due to the early in-
vasion of the adjacent bone tissue (T4 primary tumour) (Seoane et al., 2006) 
yet could present without time delay. Additional difficulties come from the 
type of data collected (e.g.: continuous variables (Wildt et al, 1995; Hollows et 
al 2000; kumar et al, 2001; kantola et al, 2002) versus categorical (Allison et al 
1998b; kerdpon et al 2001a), from the different sources of patient data (ques-
tionnaires, interviews, clinical records) and also from the already mentioned 
patient memory bias.
Different velocities of tumour growth may well also explain with some 
tumours remain small in size in spite of delay. Even though some studies re-
lated diagnostic delay and tumour stage (Brouha et al 2005), it is possible that 
the relationship between delay and advanced tumour stage is veiled by the 
fact that certain cancers remain silent during the initial stages and induce 
symptoms only when they reach and advanced phase (Scott, 2005). This be-
ing, tumour growth rate would act as a confounding factor in the relationship 
between diagnostic delay and tumour stage, since patients with aggressive tu-
mours and poor prognosis do not usually present diagnostic delay, while tu-
mours with low proliferation rates demonstrate good prognosis despite long 
diagnostic delays (kaufman, 1980; Evans, 1982; Allison, 1998a).
A recent meta-analytical study has shown that diagnostic delay is broadly 
associated to more advanced stages in oropharyngeal cancers. This associa-
tion resulted to be specially strong when the analysis was restricted to oral 
cancer (pooled RR, 1.47; 95% CI: 1.09-1.99) and when the delay was longer 
than one month (pooled RR, 1.69; 95%CI: 1.26-2.77) (gomez et al 2009). The 
probability for delayed patients to present an advanced stage of oral cancer 
at diagnosis in this report was 25% higher than that of non-delayed patient. 
Nevertheless these data should be interpreted with caution since all 9 studies 
considered in the analysis were cross-sectional in nature, with retrospective 
designs and a potential for recall bias.
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Table 1. Association between diagnostic delay and advanced 
disease stage for oro pharyngeal carcinomas. 
Study Tumour site Age-range (years)
Gender
M/F
Delay
Non-
advanced/
Advanced
OR
(95%CI)
Guggenheimer, 
1989 Oral & OPH NS NS 54/19 0.5 (0.2-1.2)
Gorsky,1995 Oral & OPH 10-99 363/180 259/1323 1.0 (0.5-2.1)
Allison, 1998 Oral & Phar-ynx 34-91 134/54 67/84 3.0 (1.8-4.8)
Kerdpon, 2000 Oral 32-93 117/44 42/78 1.7 (1.0-2.9)
Kantola, 2001 Tongue 26-85 34/41 6/20 3.4 (1.0-11.7)
Pitiphat, 2002 Oral & Phar-ynx 26-91 65/40 38/15 0.8 (0.3-2.3)
Carvalho, 2002 Oral & OPH 15-82 363/54 78/224 0.8 (0.5-1.4)
Onizawa, 2003 Oral 33-96 100/52 41/32 0.7 (0.3-1.4)
Scott, 2004 Oral 22-89 157/88 48/59 1.3 (0.8-2.2)
NS: not stated; OPH: Oropharynx; M: male; F: female; OR: odds ratio; CI: confidence interval
1.6. Diagnostic delay and survival to oral cancer
 The number of studies focusing on the relationship between diagnostic delay 
and survival to oral cancer are scarce (Table 2), and their results show sub-
stantial discrepancies: on the one hand the strength of the association did not 
reach signification (Ho, 2004), but on the other hand there seems to exist a 
strong relationship when referral delay is considered (kantola, 2001; Sando-
val, 2009), more specifically: when longer than month, these delays worsen 
survival to oral and oropharyngeal cancer (Sandoval. 2009), however when 
tumour aggressiveness is considered, the role of diagnostic delay could not be 
demonstrated (Seoane, 2010).
Reports on tongue cancer are particularly paradoxical, as referral delays 
worsen survival, but professional delay behaves as a protective prognostic fac-
tor with shorter delays showing a trend towards impaired survival (kantola, 
2001; Teppo 2008). The impact of delays on survival was apparently unrea-
sonable, as shorter delays impaired survival. This paradoxical circumstance 
, where diagnostic delay, tumour stage and tumour prognosis are inversely 
related, has been previously described in breast, cervix, lung, colon, renal and 
urethral cancer and seems to suggest that stage at diagnosis and survival are 
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affected more by the biology of the cancer (rapid tumour growth) than by a 
delayed diagnosis. 
These conclusions demand more studies assessing the impact of diagnos-
tic delay on the course of oral squamous cell carcinomas with sound epide-
miologic design (prospective), standardised criteria for diagnostic delay and 
protocols to minimise recall bias. These future investigations would also ben-
efit from considering in their statistical analyses the biological features of the 
tumour and treatment delays. 
Table 2. Estudios que relacionan el retraso  
diagnóstico en CO y la supervivencia 
Author Country Data  collection
Tumor 
Site SS
TNM 
n (%)
P D
RR 
(95%CI)
Prof D
RR 
(95%CI)
Ref D
RR 
(95%CI)
T D
RR 
(95%CI)
Kantola Finland 1974-1994 Tongue 75
I  9 (12% )
II 22 (29.3%)
III 33 (44%)
IV 11 (14.7%)
- -
6.3
(1.7-
22.9)
-
Teppo Finland 1986-1996 Tongue 62
I  8 (13%)
II 22 (35%)
III 25 (40%)
IV 7 (11%)
0.58
(0.36-
0.93)
1.07
(0.68-
1.70)
- -
Seoane Spain 1997-2002 Oral 63
I 9 (14.3%)
II 20 (31.7%)
III 10 (15.9%)
IV 24 (38.1%)
- - - 1.0(0.9-1.1)
Sandoval Spain 1996-1999
Oral 
&
 OPH
146
I 15 (10.3%)
II 30 (20.5%)
III 35 (24%)
IV 66 (45.2%)
- - 2.1(1.0-4.3) -
SS: sample size; PD: patient delay; Prof D: professional delay; Ref D: referral delay; TD: Total 
Delay; RR: relative risk; OPH: oropharyngeal
This is important, as the clarification of this hypothetical relationship between 
diagnostic delay and survival to oral cancer may condition early oral cancer 
detection strategies either by strengthening programmes for diminishing di-
agnostic delay or favouring oral cancer and precancer screening strategies.
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1.7.  Strategies to minimise diagnostic delay in oral cancer
A delay when dealing with oral cancer diagnosis is unacceptable. Despite the 
quickness in obtaining a diagnosis does not ensure an early-stage tumour, it is 
essential for reducing cancer mortality (Horowitz, 1995). Specific educational 
interventions on the population, focused on risk groups (self-exploration) and 
on the clinicians (index of suspicion) are needed to achieve this goal. These in-
terventions should provide sound knowledge of the disease presentation and 
competences for visual/tactile diagnosis. Additional improvements to ease ac-
cessibility to health care and the implementation of clear referral schemes for 
patients with suspicious lesions would also contribute to this purpose. An ex-
ample of these schemes would be the “Two weeks wait”, rolled out in Decem-
ber 2000 in the United kingdom for referral of head and neck cancer patients 
from primary care to specialised centres (Department of Health, 2000). The 
audit of this programme showed a high proportion of non-malignant lesions 
being referred through the fast-track system, highlighting a low sensitivity 
among the general practitioners and stressing need for better visual detector 
guidelines. This assessment stressed the need for the primary care clinician 
to know which kind of cases should be sent to the specialist (all suspicious 
lesions and all suspicious borderline lesions). As it is difficult to detect oral 
cancer lesions at early stage, several ancillary diagnostic tests have been de-
veloped to improve diagnostic performance, such as toluidine blue staining, 
chemiluminiscence and autofluorescence (Trullenque –Eriksson, 2009).
1.7.1. Toluidine blue
Tolonium chloride (toluidine blue) has been assessed as diagnostic aid for 
diagnosis of oral malignant and premalignant lesions by a number of studies 
(Epstein, 2007; Epstein, 2008; Epstein, 2009). These results were studied from 
a meta-analytical perspective in 1989, revealing sensitivities ranging from 
93.5% to 97.8% and specificities from 73.3% to 92.9% (Rosenberg, 1989), this 
good performance of the product was somehow spoiled by the serious meth-
odological limitations observed in some of the original reports. A more recent 
report by Lingen (2008) described sensitivities for the detection of oral cancer 
ranging from 0.78 to 1.00, and specificities of 0.31 to 1.00. A comprehensive 
analysis of the current evidence suggest that toluidine blue ins good at detect-
ing carcinomas, but its sensitivity in detecting dysplasia is significantly lower 
(Epstein, 2008; Lingen, 2009).
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1.7.2. Light-based detection systems.
These systems are based upon the structural and metabolic changes the oral 
mucosa undergoes during the carcinogenesis process. These phenomena in-
duce different absorbance and refractance profiles when exposed to different 
sources of light or energy (Epstein, 2009).
1.7.2.1. ViziliteÒ  (Zila Pharmaceuticals, Phoenix, AZ)
A number of cross-sectional studies assessed this chemiluminiscence device 
with high scores in sensitivity (100%), as every patient had previously visual-
ized mucosal lesions, but low specificity values (0-14.2%) with high percent-
ages of false positives. This device has proved a high capacity to emphasize 
certain visual features of the lesion, such as brightness and lesions limits (Ep-
stein, 2009), but it does not aid in the identification of a premalignant or ma-
lignant oral lesion (Farah, 2007). A combination of Vizilite and toludine blue 
(ViziLite Plus) has been introduced to reduce the number of false positives 
but, although both specificity and predictive positive values improved, the 
scientific evidence on this combination published to date is scarce (Epstein, 
2008).
A different system based on the same principles of ViziLite (Microlux/
DL, Danbury,USA) has been designed, which illuminates the lesion with a 
diffused light from a light-emitting diode. When assessed prospectively, it 
showed a sensitivity of 77.8% and a specificity of 70.7% (McIntosh, 2009). 
Some reports point that chemoluminiscence could be useful to identify lesions 
hidden to incandescent light sources, but no evidence supports this theory.
1.7.2.2. Tissue fluorescence imaging  
The VELscopeÒ system (Visually Enhanced Lesion Scope; LED Dental Inc., 
White Rock, USA) uses autoflorescence technology to detect the loss of fluo-
rescence in visible and non-visible oral lesions. Its sensitivity ranged from 97 
to 100%, and proved useful to establish safer surgical margins in tumour exci-
sion (Huber, 2009), but no methodologically sound studies back the useful-
ness of this system as ancillary diagnostic tool when dealing with malignant 
or premalignant lesions in lower-risk, primary care patients (Lingen, 2008; 
Epstein, 2009).
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1.7.2.3. Tissue fluorescence spectroscopy
This system produces various excitation wavelengths that are received by a 
spectrograph and recorded on a computer (Fedele, 2009). Its main advantage 
is the elimination of the subjective interpretation of the changes in the fluo-
rescence of the tissues, but its main indication is limited to the exploration 
of previously visually-diagnosed small lesions. This device has shown a high 
sensitivity and specificity to differentiate healthy mucosa from malignant oral 
lesions (De Veld, 2005).
Regardless of these promising technologies, the path until these systems 
enhance visual detection beyond what is achieved through conventional vi-
sual and tactile examinations is still to be covered.
1.8. Oral cancer diagnosis at asymptomatic phases of the disease
The studies on diagnostic delay consider only the asymptomatic stage of the 
disease, which represents a minor part of the disease natural history. The 
equivocal relationship between diagnostic delay and certain outcomes of in-
terest, like tumour stage and survival to the disease, suggest the need to priori-
tise the early diagnosis of oral cancer through screening programmes aimed 
at detecting the disease during its asymptomatic phases, as there is evidence 
demonstrating that oral visual inspection is satisfactorily sensitive to detect 
oral precancers and that can improve oral cancer stage at diagnosis. Moreover, 
community-based screening on these bases may thus decrease oral cancer 
specific mortality amongst people who use tobacco, alcohol or both (kujan, 
2006).
However, it has to be born in mind that these kind of approaches can also 
be affected by biases, like the so-called “length-time bias”, where the possibil-
ity to detect aggressive oral carcinomas by screening is low due to the fact that 
the period until symptoms arise is short. On the other hand, less aggressive 
tumours with longer periods until symptoms are easier to detect by screening; 
this phenomena may make think that an early diagnosis improves prognosis, 
when what actually happens in that this approach detects mostly tumours bio-
logically less aggressive (van der Waal, 2011).
Another potential bias affecting this kind of programmes would be the 
“lead-time bias”, where survival to oral cancer may seem better when cases 
are diagnosed early but what actually happens is that cases are detected ear-
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lier though patients do not live longer than would live if the neoplasm were 
diagnosed during the symptomatic period of the disease (van der Waal, 2011).
A different approach would be the case-search: the patient is explored 
searching for subclinical disease. This procedure is not so demanding but in 
any situation, the screening test should be easy, safe, reproducible and valid, 
as well as accepted by the population and by the healthcare workers involved, 
and should also assess risks, nuisances and costs. In areas with low prevalence 
of oral cancer, screening programmes result in a reduced detection rate. How-
ever, opportunistic high-risk screening (involves offering patients a screen 
when they attend a clinic for some other, unrelated reason), particularly in 
general dental practice, may be cost-effective (Conway, 2006). This screening 
may be more effectively targeted to younger age groups, chiefly 40-60 years 
old (Conway, 2006). Moreover, new educational strategies are needed to iden-
tify populations at particular risk; younger people (Farshadpour, 2007) and 
non-smoking and non-drinking oral cancer patients (females, old at disease 
presentation). Thus, the range of ages for systematic oral examination should 
be broaden.
Opportunistic screening by general dentists includes a systematic review 
of the oral mucosa during regular dental care. About 83%-86% of European 
and American gDPs declared to perform a systematic exploration of oral soft 
tissues to rule out oral cancer. Despite this fact, their ability to make a cor-
rect positive detection of oral cancer (sensitivity) remains low, as reported 
scores varied from 0.4 to 1.0. The specificity ranged from 0.31 to 0.92; these 
low values would mean that patients with oral carcinomas would not be ad-
equately referred for the decisive diagnostic and treatment (Downer, 2006). 
Despite that, selective opportunistic screening may be a realistic and effective 
solution, as detections of oral and oropharyngeal squamous cell carcinomas 
during a non-symptom-driven examination has demonstrated to be related to 
lower stages at diagnosis although there is insufficient evidence to determine 
whether screening by visual and tactile examination in asymptomatic patients 
alters disease-specific mortality (Downer, 2006). Of course, it has to be kept in 
mind that “insufficient evidence” only means that there are no methodologi-
cally sound studies available to support a given technique or approach.
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2. JUSTIfICATION
Oral cancer is considered to be one of the highest incidence rating cancers, 
ranking between the sixth and the eighth place in the mortality classification 
by cancer type on a global scale, probably because its final diagnosis is mainly 
obtained once the disease has already spread out (TNM III-IV).
Different studies have previously dealt with the influence of the time in-
terval employed to establish a histological diagnosis on tumour stage at diag-
nosis. Recently our group has done a meta-analysis that seems to prove a clear 
association between tumour diagnostic delay and late-stage diagnosis of the 
disease. However, the information about the relationship between diagnostic 
delay in head and neck cancer is scarce and frequently ill-founded, particu-
larly about oral cancer, and survival. It is also difficult to explain the lack of as-
sociation or inverse association that has been observed by some authors when 
they have tried to relate a longer diagnosis delay with a higher mortality rate 
in this type of tumours. Nonetheless, the identification of the specific charac-
teristics of the tumour and the clinical characteristics of the patients at high 
risk of late-stage diagnosis of oral cancer, may allow us to design strategies 
aimed at early diagnosis of these tumours and creating educational contents 
for future educational interventions for both high risk patients and profes-
sionals committed with the diagnosis of this disorder.
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3. OBJECTIvES
To create hypothesis that could explain the inconsistency of the association 
between diagnostic delay and survival to oral cancer.
To create a systematic review and meta-analysis to evaluate the relationship 
between diagnostic delay and survival to oral cancer. 
To find out what are the clinical characteristics of the patient and the histo-
pathological characteristics of the tumour that are associated with late stage 
diagnosis of the disease.
To find out what are the oral cancer preventive actitudes of the spanish den-
tists who particip in oral cancer continuos medical education programs.

BIOlOGICAl 
hyPOThESIS: 
Does tumour biological 
behaviour influence 
prognosis more than 
diagnostic delay 
in oral cancer?
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4. BIOlOGICAl hyPOThESIS: DOES TUMOUR 
BIOlOGICAl BEhAvIOUR INflUENCE 
PROGNOSIS MORE ThAN DIAGNOSTIC 
DElAy IN ORAl CANCER?
Abstract
Worldwide, oral cancer has one of the lowest survival rates (lethal disease for 
over 50% of cases diagnosed annually) and remains unaffected despite recent 
therapeutic advances.
Unfortunately, almost half of the oral cancers are diagnosed at stages III 
or IV, probably due to delays in reaching a definitive diagnosis. Many pre-
ventive approaches (secondary prevention) have been designed assuming the 
logical hypothesis that the longer the diagnostic delay, the more advanced the 
cancer and the worse the prognosis. However, a number of studies failed to 
prove this association or even found an inverse relationship.
We hypothesize that tumour’s biological heterogeneity in terms of ag-
gressiveness may explain shorter delays linked to advanced stages and bad 
prognosis. The assumption of this hypothesis would entail favouring oral can-
cer and precancer screening strategies at the preclinical stage of the disease, 
and therefore strategies of opportunistic screening for oral cancer and precan-
cer on asymptomatic at risk population should be reinforced.
Keywords:  mouth neoplasms, prognosis, delayed diagnosis, biological beha-
viour, squamous cell carcinoma.
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Introduction
Oral cancer is a worldwide public health issue [1,2] whose incidence and mor-
tality rates are steadily growing in Europe (eg: France, Hungary, Spain and 
Croatia), Brazil and South-Eastern Asia (Sri Lanka, Pakistan, Bangladesh and 
India) [3].
This neoplasm retains one of the lowest survival rate (lethal disease for 
over 50% of cases diagnosed annually) which remains unaffected despite re-
cent therapeutic advances. This is particularly worrying as rising trends in 
oral cancer incidence are being reported for young and middle-age men from 
Brazil, India, certain areas of Europe and the USA [3,4].
Tumour stage at diagnosis remains the most important prognostic mark-
er for oral squamous cell carcinoma [5]. Unfortunately, almost half of the oral 
cancers are diagnosed at stages III or IV with poor 5-year survival rates (20% 
to 50%) depending upon tumour sites, probably due to delays in reaching a di-
agnosis [6-9]. It has been suggested that if these malignancies were diagnosed 
and treated at earlier stages, survival rates would exceed 80% [10].
A number of researchers have revised the concept of diagnostic delay in 
head and neck cancer, however these investigations do not use homogeneous 
criteria [8,9,11], and comparative analyses are not always possible [8,9]. Now-
adays, the concept of delay in diagnosis is often broken into two categories, 
namely patient delay –the period between the patient first noticing a symp-
tom or sign and the first consultation to a healthcare professional concerning 
that symptom or sign [8,9,12,13] and provider/professional delay –the period 
from the patient’s first consultation with a healthcare provider and the defini-
tive pathological diagnosis [12,13]. The overall diagnostic delay (total delay) 
would elapse from the first symptom or sign until the definitive histological 
diagnosis [8,9,12,13].
It seems reasonable to assume that a cancer’s stage at diagnosis is a func-
tion of the length of time it had been developing prior to diagnosis (logical 
hypothesis). Thus the longer the delay, the more advanced the disease would 
be and a worse prognosis should be expected [14]. However, many studies 
either failed to prove this association [15-23,25] or demonstrated an inverse 
relationship (shorter delays linked to more advanced stages) [19,22,24,25]. 
Although methodological flaws could partially explain this paradox, new hy-
potheses seem to be necessary in this field.
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The hypothesis: Biological heterogeneity of oral carcinomas.
The inconsistencies observed in the association between longer delays in oral 
cancer diagnosis and worse outcome in terms of clinical stage and survival 
could be related to variability in the biological behaviour of these tumours. 
Differences in tumour aggressiveness would explain tumour’s stage at diag-
nosis and patient survival better than the mere length of the diagnostic delay 
(Fig 1).
Fig. 1. Biological hypothesis of diagnostical delay in oral cancer
Supporting the hypothesis
Tumours of a single cancer type can appear to be similar but grow at very dif-
ferent rates and with different levels of aggressiveness [26]. Patients with fast-
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growing tumours may be diagnosed relatively rapidly, but often an advanced 
stage has already been reached, given the nature of the disease [24]. Shorter 
patient and professional delays have been associated to advanced stage at di-
agnosis in some oral cancer series [19,22,24,25,27,28]. 
We have recently demonstrated, by means of a multivariate study, that 
when the analysis is adjusted for tumour stage at diagnosis (I-II vs., III-IV), 
proliferative activity arises as an independent prognostic factor for survival 
and diagnostic delay does not influence this outcome [29]. These results seem 
to suggest that survival to oral cancer is affected more by the rapid tumour 
growth of the cancer than by delays in the diagnosis.
Testing the hypothesis
It has been suggested that cancer biology may be more important than diag-
nostic delay. In order to test the feasibility of this hypothesis and to assess the 
impact of diagnostic delay on the course of oral squamous cell carcinomas, 
new studies with sound epidemiologic design to minimize the biases identi-
fied in the existing reports (selection, information, confounding, survival and 
lead-time biases) are needed [15-25]. It is mandatory to utilize standardised 
criteria for measuring the diagnostic delay and to develop protocols to miti-
gate recall bias [8,9]. The use of structured questionnaires at the primary care 
level and the participation of patient relatives could increase the quality of the 
information on diagnostic delay [8,27,28].
It seems advisable to conduct population-based studies with an important 
prospective component and an adequate sample size that consider exclusively 
incident oral cancer cases using patient survival as the main outcome. These 
studies should also account for potential confounding variables, such as age, 
gender, tumour site, co-morbidity and treatment –including also delay during 
the treatment phase- because it can influence outcomes [13]. A key point to 
assess oral cancer heterogeneity and its biological potential is the histological 
analysis of the whole tumour, otherwise there could exist a bias, particularly 
in large tumours. Future studies would benefit from a quantitative analysis 
approach (i.e.: analysis by flow cytometry of larger tumour samples), as this 
procedure permits the study of the fraction of proliferating tumour cells and 
the amount of fraction of spontaneous cell loss, which influence the tumour’s 
growth rate [51]. Moreover, gene expression signatures generated from DNA 
microarray analysis have proved to be predictive biomarkers for clinical out-
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come [52] and could be used to infer the clinical behaviour of the oral cancer 
and to adjust this way the actual weight of diagnostic delay on patient survival.
Discussion
Oral cancer main features (tumour size and nodal status) appear to correlate 
well with tumour growth chronology [31,32]. This paradigm focused research 
on the possibility that diagnostic delay contributed to the spread of the dis-
ease. Despite this theory could be confirmed for a number of tumours, no 
definitive conclusions could be drawn for oral cancer [8,9,33-39].
Theoretical tumour growth assumes no treatment and no cell lost, but 
cell loss increases when a tumour grows and outstrips its blood supply. Neo-
plasms typically grow progressively, but even within a single tumour type 
there are significant variations that lead to unpredictable differences in the 
pattern, speed of onset, and progression of patient symptoms that would de-
finitively condition the moment of the diagnosis [26].
When dealing with delays in diagnosis, the beginning of the study has 
to be the recognition of the signs and symptoms by the patient. This fact is 
critically affected by his/her psychosocial characteristics, some of them able to 
predict diagnostic delay and advanced tumour stage at diagnosis [30]. Simi-
lar findings were reported from a case-control study demonstrating that the 
length of diagnostic delay was significantly greater in patients with advanced 
tumour stages (TNM stage IV) [16].
However, there is no sound scientific evidence supporting an association 
between diagnostic delay in oral cancer, disease extension at diagnosis, and 
lower survival rates [15-25]. This fact may well be partially due to method-
ological flaws in the published reports to date [8,9,36,40,41].
These reports use different conceptions of diagnostic delay and are thus 
liable to misclassifications, utilize retrospective designs without strategies to 
diminishing patient’s memory bias and often break down diagnostic delay 
classifications into subgroups with small sample sizes. Studies involving tu-
mours of different locations introduce confounding factors in the analysis, as 
the patient self-perception and self-exploration abilities depend on the site of 
the tumour [19,37,42]. For example, gingival locations are associated to ad-
vanced stages at diagnosis due to the early invasion of the adjacent bone tissue 
(T4 primary tumour), yet could present without time delay [38]. Additional 
difficulties come from the type of data collected (e.g.: continuous variables 
[19,27,30] versus categorical [41,43]), from the different sources of patient 
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data (questionnaires, interviews, clinical records) and also from the already 
mentioned patient memory bias.
Different velocities of tumour growth may well also explain why some tu-
mours remain small in size in spite of delay. Even though some studies linked 
diagnostic delay and advanced tumour stage, it is possible that the relation-
ship between delay and advanced tumour stage is veiled by the fact that cer-
tain cancers remain silent during the initial stages and induce symptoms only 
when they reach an advanced phase (silent tumour hypothesis) [7]. This be-
ing, the tumour growth rate would act as a confounding factor in the relation-
ship between diagnostic delay and tumour stage since patients with aggressive 
tumours and poor prognosis do not usually present diagnostic delay, while 
tumours with low proliferation rates demonstrate good prognosis despite long 
diagnostic delays [44,45].
Despite the aforementioned, a recent meta-analytic study by our re-
search group has shown that diagnostic delay is broadly associated to more 
advanced stages in oropharyngeal cancers. This association resulted to be es-
pecially strong when the analysis was restricted to oral cancer (pooled RR, 
1.47; 95%CI: 1.09 – 1.99) and when the delay was longer than one month 
(pooled RR, 1.69 95%CI: 1.26 – 2.77) [9]. The probability for delayed patients 
to present an advanced-stage oral cancer at diagnosis in this report was 25% 
higher than that of a non-delayed patient. Nevertheless, these data should be 
interpreted with caution since all 9 studies considered in the meta-analysis 
were cross-sectional in nature, with retrospective designs and a potential for 
recall bias [9].
The number of studies focusing on the relationship between diagnostic 
delay and survival to oral cancer are scarce, and their results show substantial 
discrepancies: on the one hand the strength of the association did not reach 
signification [46], but on the other hand there seem to exist a strong relation-
ship when referral delay is considered [27,47]. More specifically: when longer 
than a month, these delays worsen survival to oral and oropharyngeal cancer 
[47]. However, when tumour aggressiveness is considered, the role of diag-
nostic delay could not be demonstrated [29]. Moreover, confounding effects 
of lead-time bias could condition the association between diagnostic delay 
and survival to the tumour [26].
Reports on tongue cancer are particularly interesting [27,28] because the 
impact of diagnostic delays on survival are apparently unreasonable: shorter 
delays impaired survival. This paradoxical circumstance, where diagnostic de-
lay, tumour stage and tumour prognosis are inversely related, has been previ-
ously described in endometrial, cervix, lung, colon, renal and urethral cancer, 
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and seems to suggest that stage at diagnosis and survival are strongly affected 
by the biological aggressiveness of the cancer [8, 26,48].
Oral cancer is a relatively proliferating tumour with proven heterogeneity 
in its biological behaviour. Specifically HPV negative, aneuploid and TP53-
mutated tumours have shown less favourable prognoses [49]. Moreover, the 
expression of different oncogenic markers including , p16, p21, p27, MDM2, 
MgMT, EgFR, ERBB2, RARB, MyC, BCR-ABL1, RAS, CCND1, STAT-3, 
and VEgF, induce a more rapid clinical course [50] that considerably reduces 
the opportunities for a diagnosis at early stages of the disease. Alternatively, 
HPV positive oral cancers, mostly oropharyx, mainly wild-type TP-53 have 
demonstrated favourable prognosis [49].
Conclusion
Advanced tumour stages in oral cancer have been conventionally ascribed to 
delays in reaching a diagnosis. Surprisingly, there is a lack of sound scientific 
evidence supporting this traditional association between diagnostic delay and 
disease extension and survival. However, different oral cancer genetic profiles 
result on a wide variability in the biological behaviour of the tumour and may 
justify the hypothesis of the biological heterogeneity of diagnostic delay in 
oral cancer.
An important issue is the difficulty in comparing oral cancer subtypes 
with very different behaviours. Thus rapidly growing tumours –where the 
quickness in obtaining a diagnosis does not guarantee and early stage- have 
short periods for a potential screening, whereas slowly growing tumours per-
mit a longer potential screening period. This circumstance should be taken 
into account when designing interventions aimed at reducing the duration of 
the diagnostic pathway.
In this sense, the corroboration of this hypothesis would imply favouring 
oral cancer and precancer screening strategies, and therefore opportunistic 
screening for oral cancer and precancer on asymptomatic, at-risk population 
should be reinforced. 
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Abstract
Objective: To address the contradictory information on the role of delay in 
diagnosis in head and neck cancer survival.
Study Design: Systematic review and meta-analysis.
Search Strategy: Search on MEDLINE (1966 to March 2011), EMBASE 
(1980 to March 2011), and ISI proceedings (from inception to March 2011) 
The terms used were (“Head and neck cancers”) AND (“delay” OR “prognos-
tic” OR “survival”) both in MeSH terms and free-text words. The reference 
lists of the retrieved articles were also revised manually to identify other po-
tentially relevant papers. All searches were independently undertaken by two 
clinicians and one epidemiologist, and the results merged.
Setting: primary and specialized care levels.
Participants: Meta-analysis of data from papers on the subject published 
from 1966-2011.
Main outcome measures: Survival.
Methods: After search in Medline and other databases, we computed 
pooled Relative Risks (RR) and 95% Confidence Interval (95%CI) from the 
10 studies retrieved. 
Results: The estimate of the relative risk of mortality related to any di-
agnostic delay (either patient or professional delay) was 1.34 (95%CI 1.12-
1.61). Referral delay was associated with a 3-fold increase of mortality. Total 
delay was marginally related with mortality (RR: 1.04, 95%CI: 1.01-1.07). By 
anatomic location, pharynx cancer shows the highest association (RR: 1.68, 
95%CI: 1.22-2.31). 
Conclusions: Diagnostic delay is a moderate risk factor of mortality from 
head and neck cancer. However, part of the effect observed may be due to 
residual confounding (confounding from unknown variables that is not elimi-
nated by adjustment).
Keywords: meta-analysis, head and neck cancer, survival, diagnostic delay
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Introduction
Head and neck cancer is ranked as the eighth leading cause of cancer death 
worldwide. 1-4 Several factors have been assessed as independent prognostic 
markers for head and neck cancer, but tumour stage at diagnosis is still recog-
nised as the most important one.3 Advanced stages are frequently associated 
with high mortality rates: the reported five-year survival rate for patients with 
localized disease is 82%, that of patients diagnosed with regional disease is 
51% and that of patients with distant metastasis only 27.6%.4 This poor five-
year survival rate has remained unchanged for more than three decades.3,4 
Unfortunately, almost half of the head and neck cancers are diagnosed at ad-
vanced stages (III or IV), probably due to delays in reaching a diagnosis.5,6 
Nowadays, diagnostic delay is most often categorised as (i) patient delay 
– the period between the patient first noticing a symptom and their first con-
sultation with a health care professional concerning that symptom;6,12,13 and 
(ii) provider/professional delay – the period elapsed between the patient’s first 
consultation with a health care professional and the definitive pathological 
diagnosis. 6,12,13 The overall diagnostic delay (total delay) includes the period 
elapsed since the first symptom or sign until the definitive diagnosis. 
Several research groups have assessed the role of diagnostic delay in the 
staging of the tumour, and by extension, in the survival from head and neck 
cancer. Heterogeneous criteria were used in this assessment. Different types 
of data were used (continuous 15 and categorical data8,14 ) and different sources 
of information on patient delay were collected (standard questionnaires, in-
terviews, hospital records, etc.). This heterogeneity in the assessment, along 
with variations in tumour biology, may explain the absence of a consistent 
relationship between diagnostic delay and stage of the tumour in the litera-
ture.3,5,6 While several research groups did not find sufficient evidence,7-9 some 
others have recently described a significant relationship between advanced 
stages and diagnostic delay. 6,10,11 Despite these shortcomings, diagnostic delay 
has recently been recognised as an independent prognostic factor for survival 
to head and neck cancer. 3,7,11,15-17 
In view of this inconsistent data, we undertook a systematic review and 
meta-analysis to assess the relation between diagnostic delay and survival in 
head and neck cancer.
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Material and methods
literature search
We performed a systematic search on computerized databases including 
MEDLINE (1966 to March 2011), EMBASE (1980 to March 2011), and ISI 
proceedings (from inception to March 2011) for papers published in any lan-
guage. The abstracts of the articles were screened to exclude irrelevant studies. 
The terms used were (“Head and neck cancers”) AND (“delay” OR “prognos-
tic” OR “survival”) both in MeSH terms and free-text words. The reference 
lists of the retrieved articles were also revised manually to identify other po-
tentially relevant papers. All searches were independently undertaken by two 
clinicians and one epidemiologist, and the results merged.
Studies were included if they fulfilled the following criteria: 
(i). Presented original data from survival studies with a survival follow-up 
of at least 24 months, starting from the date of the histological diagnosis of a 
squamous cell carcinoma.
 (ii). The sample was made of patients with head and neck cancer, excluding 
odontogenic, ear, skin and salivary glands tumours. 
(iii). The exposure of interest in the study was patient delay (the time from 
the patient’s first awareness of symptom or sign to the first consultation with 
a physician or dentist); or professional delay (PDI – presentation to diagnosis 
interval- the time from the patient’s first consultation with a physician or a 
dentist to the date of final histological diagnosis); or total diagnostic delay (the 
sum of the patient and professional delay); or referral delay (difference between 
the date of first symptom and the date of the referral letter transferring the 
patient to the secondary care level).
Quality assessment
We assessed study quality by use of a five-point binary scale (yes/no) that we 
specifically developed for this study. The scale is based on the Newcastle-Ot-
tawa scale18 with modifications in view of standard guidelines.19 Throughout 
this assessment, when the information on a specific item was not provided 
by the authors, we graded this item as “no”. The quality scoring was indepen-
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dently undertaken by two researchers (BT & JS). The first item assessed the 
source of the outcome date. One point was given if the date of death was ascer-
tained through clinical history or death certificate and zero point if otherwise. 
The second item assessed the cause of death (one point if it was clearly due to 
the cancer diagnosed previously, including metastasis, and zero point if non-
specific mortality was measured). The third item assessed the follow-up time 
(one point if follow-up was 4 years or more and zero if less than 4 years). The 
fourth item assessed the definition of delay. One point was given if inception 
was clearly defined and zero if not. The last item concerned adjustment for 
confounding factors. One point was given if the analysis was adjusted for sex, 
age and other factors and zero if not.
Statistical analysis
The study-specific adjusted log relative risks were weighted by the inverse of 
their variance to compute a pooled RR and its 95% CI. We computed both 
fixed-effects and random-effects pooled estimates. The fixed-effects model 
assumes that there is no between-study variance (i.e. that the results of the 
studies used in the meta-analysis are homogeneous and their variation is a 
result of sampling only). The random-effects model, by contrast, assumes that 
study results are heterogeneous. The random-effects model yields pooled re-
sults that are less precise (have wider CIs) but are closer to the true value in the 
event that heterogeneity exists. To quantify the heterogeneity, the proportion 
of the total variance due to between-study variance (the Ri statistic) was cal-
culated.20 For each analysis, we used random effects results whenever the test 
statistic for heterogeneity was significant, and fixed effects estimates other-
wise. For each study, we estimated the relative risk of mortality for “any delay” 
by pooling the estimates of each category of delay presented by the authors of 
the study. When only one category of delay was presented, we used its estimate 
and included it in the category “any delay”.
To assess publication bias visually, a funnel plot was used.21 Because fun-
nel plots have several limitations and represent only an informal way to detect 
publication bias,20  the test suggested by Egger et al. was also applied.22 All 
analyses were performed using the HEpiMA software, version 2.1.3 23
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Results
A total of 1016 articles were accessed through the literature search strategy. 
Review of the titles, abstract, and in some cases the full text, excluded 1001 
articles. We further excluded 7 studies due to either unclear or arbitrary defi-
nition of diagnostic delay,24 or lack of information on any of the variables of 
interest.24-30 We finally included 10 studies that were published in 8 different 
articles between 2001 and 2010 (Table 1 and figure 1). The period of data 
collection spanned between 1974 and 2002. The anatomic location of the tu-
mours varied widely between studies: 2 studies presented data on tongue tu-
mours, 3 on oral or oropharynx cancer, 2 on pharynx, 2 on larynx and 1 on 
glottis tumours. The sample size varied between 66 and 544 patients. All stud-
ies but one were carried out in European countries.7,9,10,15,17,31-33 One article pro-
vided independent data for oral, pharynx and larynx cancers.31 Five studies 
presented data on patient delay, five on professional delay, 2 on referral delay 
and 2 on total delay. One study presented data on professional delay that were 
clearly erroneous (point estimate of the relative risk out of the range of the 
confidence interval). 9 This erroneous estimate was not included in our meta-
analysis. Distribution by tumor stage varied widely between studies: from 2% 
to 50% for TNM stage I and from 0% to 68% for TNM stage IV. 
Table 2 lists the pooled effect estimates for all 10 studies and diverse sub-
groups. The random effects pooled estimate from all studies was 1.34 (95%CI 
1.12-1.61) with substantial heterogeneity (Ri=0.95). Although patient and 
professional delays were associated with increased risk of mortality, both esti-
mates did not reach statistical significance. Referral delay estimate, although 
based on 2 studies only, is associated with a statistically significant 3-fold in-
crease of mortality. On the contrary, total delay is apparently not related with 
the outcome (pooled RR: 1.04, 95%CI: 1.01-1.07). 
Although the funnel plot (figure 2) indicates a slight skewness to the right, 
the asymmetry test yielded a p-value of 0.83 indicating absence of asymmetry. 
Publication bias is then unlikely to occur with the data at hand.
By anatomic location, pharynx cancer shows the highest association be-
tween delay and mortality (Pooled RR: 1.68; 95%CI: 1.22-2.31, low heteroge-
neity). 
To assess the possible confounding effect due to the stage of the tumor, 
we stratified our analysis into 2 subgroups: studies that included 60% or more 
of advanced stages (TNM III and IV) and studies with less than 60% of ad-
vanced stages. The pooled RR in the first group was 1.74 (95% CI: 1.30-2.33) 
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with no heterogeneity, and in the second group 1.19 (0.99-1.44) with consid-
erable heterogeneity.  
When we restricted the analysis to retrospective studies, we obtained a 
pooled estimate that showed an increase in the risk of about 60%. The risk 
increase for partially prospective studies was substantially lower. 
The data of the studies included in this meta-analysis were collected ei-
ther through questionnaires or by reviewing clinical records from primary 
care centers. The latter yielded a statistically significant pooled estimate of 
1.77 (95% CI: 1.14-2.73).On the contrary, no increase in the risk was observed 
for those studies that collected the data through questionnaires.
Adjustment for potential confounding factors, such as sex, was not per-
formed systematically in the studies retrieved. Those studies that adjusted for 
sex showed a minute increase in the risk of mortality that was non significant, 
unlike unadjusted studies the pooled estimate of which showed substantial 
risk increase. 
After scoring the quality of the studies on a 5 point scale, we divided the 
studies in 2 groups: those that scored 4 or more points out of five and those 
which scored less. The high quality studies showed a pooled estimate of 1.77 
(95% CI 1.14-2.75) while low quality studies showed no increase in the risk 
of mortality. Related to this issue, those studies which provided details on the 
source of mortality data yielded a higher risk increase than those with un-
known data source. 
Discussion
globally, the results of this meta-analysis showed that diagnostic delay is 
moderately related to mortality of head and neck cancers. The association was 
stronger for referral delay and for pharynx cancer, a fact that may be due to 
the rapidity at which pharyngeal cancers metastasize. 11 In addition to the ef-
fect exerted by the stage of the tumour, part of the effect of delay on mortality 
may be caused by residual confounding, distortion due to incomplete adjust-
ment for variables that could potentially distort the relation between delay 
and mortality. Sex is one of those variables. We observed that some of the 
studies included in our meta-analysis did not provide relative risk estimates 
adjusted for sex, and that the pooled effect for sex adjusted studies was much 
smaller than that of unadjusted studies.Also, the biological behaviour of the 
tumour may play the role of a confounding factor in the relation between 
diagnostic delay and survival, as patients with aggressive tumours and bad 
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prognosis do not usually present diagnostic delay whereas less aggressive tu-
mours elicit good prognosis despite a long diagnostic delay.14 Unfortunately, 
only one of the studies included in our review took the tumour proliferation 
activity into account.33
Other limitations of this systematic review and meta-analysis include the 
lack of consensus in the literature about the period beyond which the diag-
nosis of a head and neck cancer should be considered delayed: whilst some 
authors have used the mean or the median of the time distribution to describe 
and categorise the diagnostic delay,14  the latter being more frequently used 
because it is not affected by extreme values and the distributions usually have 
very wide ranges, other authors divide diagnostic delay into arbitrary inter-
vals 7,9,31,32 or define it as continuous variable without a specific time point.15 
Further, the large majority of the studies included in this meta-analysis were 
retrospective in nature. Their data are probably less accurate, due to the dif-
ficulties encountered by patients in remembering the exact date of the onset 
of symptoms. These data are prone to recall bias. In our study, we observed 
that the results from retrospective studies are overestimated. The reports from 
Finland 7,9,15,31 are probably less exposed to this bias, as primary care physi-
cians recorded each visit on a specific sheet that included the reason for at-
tendance, the diagnosis and the treatment given to the patient; and all new 
patients received at the tertiary care centres had to have a referral letter from 
their primary care physician. 
Further, key data to establish diagnostic delay, as perception of the symp-
toms and identification of the clinical signs, are clearly dependent on the 
specific location of the tumour and may explain the different magnitudes of 
association. Our results show a strong association between the existence of di-
agnostic delay and worse survival to pharyngeal carcinomas. It is remarkable 
that most of these pharyngeal cancers were diagnosed at very advanced stages 
of the disease (stage IV). 9,10,20 
On the contrary, the effect of diagnostic delay and mortality could not be 
proved for oral carcinomas, probably because 2 out of the 4 studies considered 
restricted their analysis to tongue tumours.15,20 Existing reports on tongue 
cancer are particularly contradictory, as referral delays worsen survival, 15 but 
professional delays do not. 32 This paradoxical circumstance, where diagnostic 
delay, tumour stage and tumour prognosis are not related, was previously de-
scribed in breast, cervix, lung, colon, renal and urethral cancer and seems to 
suggest that stage at diagnosis and survival are affected more by the biology of 
the cancer (rapid tumour growth) than by diagnostic delay. 34
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Although all three reports on larynx cancer show an effect of diagnostic 
delay and  poor survival rates, the investigation that reported the weakest as-
sociation did not include stage IV carcinomas in its study sample. 17 This fact 
may modify the final results by showing a weaker association than it actually 
exists for laryngeal carcinomas. Despite the fact that all reports on laryngeal 
cancer come from a specific geographical area (Finland and Denmark), it does 
not seem likely that it might compromise the generalisability of the results.
Conclusions
In view of the results obtained, we conclude that diagnostic delay is a mod-
erate risk factor of mortality from head and neck cancer. However, we can-
not rule out that, at least, part of the effect observed may be due to residual 
confounding (confounding from unknown variables that is not eliminated by 
adjustment). We consider that new studies assessing the prognostic impact of 
diagnostic delay are necessary. It is of paramount importance that optimal ad-
justment for confounding variables be carried out. These future investigations 
would also benefit from considering the biological features of the tumour and 
the delay in the treatment. 
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Table 1. Summary of the 10 studies included in the meta-analysis
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Table 2. Pooled relative risks (RR) and 95% confidence intervals 
(CI) of mortality due to delay in head and neck cancers*
Item
N
um
be
r o
f 
st
ud
ie
s
RR (95% CI) 
fixed effects
RR (95% CI)  
Random effects Ri †
Q test  
p-value
Any delay (all studies) 10 1.05 (1.02-1.07) 1.34 (1.12-1.61) 0.95 0.00005
Patient delay 5 1.54 (1.21-1.94) 1.67 (0.88-3.19) 0.85 0.00005
Professional delay 5 1.34 (1.00-1.78) 1.32 (0.66-2.66) 0.82 0.0004
Referral delay 2 2.72 (1.45-5.09) 3.17 (1.12-9.00) 0.61 0.15
Total delay 2 1.04 (1.01-1.07) 1.04 (1.01-1.07) 0.00 0.44
Oral cancer 4 1.00 (0.92-1.10) 1.27 (0.81-1.98) 0.94 0.003
Pharynx cancer 3 1.68 (1.22-2.31) 1.69 (1.05-2.72) 0.55 0.11
Larynx cancer 3 1.05 (1.02-1.08) 1.64 (0.91-2.96) 1.00 0.00005
≥ 60% of stages III and IV 4 1.74 (1.30-2.33) 1.76 (1.21-2.54) 0.37 0.19
< 60% of stages III and IV 6 1.04 (1.01-1.07) 1.19 (0.99-1.44) 0.96 0.00001
Retrospective studies 8 1.09 (1.00-1.19) 1.57 (1.11-2.24) 0.92 0.00005
Partially prospective 
studies 2 1.04 (1.01-1.07) 1.34 (0.69-2.61) 1.00 0.05
Primary care centers 7 1.50 (1.25-1.79) 1.77 (1.14-2.73) 0.81 0.0001
Questionnaires 3 1.04 (1.01-1.07) 1.04 (0.95-1.13) 0.84 0.11
Population based stud-
ies 3 1.02 (0.92-1.11) 1.16 (0.82-1.65) 0.89 0.13
Hospital based studies 7 1.05 (1.02-1.08) 1.67 (1.14-2.44) 0.99 0.00005
Source of mortality 
data known 7 1.09 (1.00-1.19) 1.68 (1.13-2.49) 0.94 0.00005
Source of data un-
known 3 1.04 (1.01-1.07) 1.17 (0.85-1.60) 0.99 0.15
Sex adjusted 7 1.04 (1.01-1.07) 1.16 (0.99-1.36) 0.94 0.0001
Sex non adjusted 3 2.77 (1.81-4.24) 2.77 (1.81-4.24) 0.00 0.42
Quality score < 4 4 1.04 (1.01-1.07) 1.04 (0.93-1.17) 0.89 0.04
Quality score ≥ 4 6 1.54 (1.28-1.86) 1.77 (1.14-2.75) 0.81 0.0002
* RR = Relative Risk; CI = confidence interval
† Proportion of total variance due to between-study variance
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Figure 2. Study-specific and pooled relative risks from studies of 
diagnosis delay and head and neck cancer
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Figure 2. Funnel plot of Relative Risk vs. log Inverse Variance of 
Relative Risk for any delay.
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6. fACTORS RElATED TO lATE STAGE 
DIAGNOSIS Of ORAl SQUAMOUS CEll 
CARCINOMA.
Abstract
Aims: To identify factors related to advanced-stage diagnosis of oral cancer to 
disclose high-risk groups and facilitate early detection strategies. 
Study design: An ambispective cohort study on 88 consecutive patients 
treated  from January 1998 to December 2003. Inclusion criteria: pathologi-
cal diagnosis of OSCC (primary tumour) at any oral site and suffering from a 
tumour at any TNM stage. Variables considered: age, gender, smoking history, 
alcohol usage, tumour site, macroscopic pattern of the lesion, co-existing pre-
cancerous lesion, degree of differentiation, diagnostic delay and TNM stage.
Results: A total of 88 patients (mean age 60±11.3; 65.9% males) entered 
the study. Most patients (54.5%) suffered no delayed diagnosis and 45.5% of 
the carcinomas were diagnosed at early stages (I-II). The most frequent clini-
cal lesions were ulcers (70.5%). Most cases were well- and moderately-dif-
ferentiated (91%). Univariate analyses revealed strong associations between 
advanced stages and moderate-poor differentiation (OR=4.2; 95%CI=1.6-
10.9) or tumour site (floor of the mouth (OR=3.6; 95%CI=1.2-11.1); gingivae 
(OR=8.8; 95%CI=2.0-38.2); and retromolar trigone (OR=8.8; 95%CI=1.5-
49.1)).
Regression analysis recognised the site of the tumour and the degree of 
differentiation as significantly associated to high risk of late-stage diagnosis.
Conclusions: Screening programmes designed to detect asymptomatic 
oral cancers should be prioritized. Educational interventions on the popula-
tion and on the professionals should include a sound knowledge of the disease 
presentation, specifically on sites like floor of the mouth, gingivae and retro-
molar trigone. More studies are needed in order to analyse the part of tumour 
biology on the extension of the disease at the time of diagnosis.
Key words: oral cancer, advanced-stage, diagnosis, cohort study.
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Introduction
Survival rates for oral cancer are very poor (around 50% overall), and no re-
markable improvements have occurred in recent decades despite advances in 
therapeutic interventions (1). Variables like age, co-morbidity, immunologi-
cal or nutritional status, size and location of the tumour, nodal status, onco-
gene expression, proliferation markers, or DNA content have been assessed 
as independent prognostic markers for oral cancer (2), but stage at diagnosis 
remains as the most important prognostic indicator for oral and oropharyn-
geal squamous cell cancers (SCCs) in such a way that advanced stages are 
frequently associated with high mortality rates (3-5).
Advances in therapy and standards of care are likely to have played a 
role in the moderate increase of survival trends, particularly for females and 
tongue cancer (6,7).
Detecting oral cancer at an early stage is believed to be the most effec-
tive means of reducing rates of death, morbidity and disfigurement from this 
disease (1), but progression in this field is slow: late-stage presentation is com-
monplace despite the existing evidence supporting that visual and tactile ex-
ploration may ease detection of oral cancer at early stages (8-10). Evidence 
also suggests that an oral examination of high risk individuals may be a cost-
effective screening strategy (11).
An important number of studies have assessed the determinants for di-
agnostic delay (period elapsed since the first sign or symptom until definitive 
diagnosis) despite its controversial part in oral cancer (12-14), but the reports 
aimed at identifying predictors for diagnosis at advanced stages are very scarce 
though tumour stage is directly related to mortality by oral cancer.
This study was designed to analyse the hypothetical factors related to di-
agnosis of oral cancer at advances stages (III-IV) in order to identify high-risk 
groups for late-stage diagnosis and facilitate early detection strategies.
Material and methods
An ambispective cohort study was designed to analyse those factors related 
to late-stage oral cancer diagnosis. The study sample was made of 88 patients 
treated at the Oral and Maxillofacial Surgery Service of the CHUAC from Jan-
uary 1998 to December 2003 that met the following inclusion criteria: patho-
logical diagnosis of OSCC (primary tumour) at any oral site and suffering 
from a tumour at any TNM stage.
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The primary sites of oral cancer were: buccal mucosa (n=5), upper and 
lower gingiva (n=15), hard palate (n=2), tongue (n=32), floor of the mouth 
(n=24) and retromolar trigone (n=10).
The variables considered included age, gender, smoking history, alcohol 
usage, tumour site, macroscopic pattern of the lesion (ulcerated, exophytic or 
mixed), co-existing precancerous lesion, and degree of differentiation.
The time interval from the self-reported date when oral cancer signs and/
or symptoms were first noted by the patient to the date of definitive pathologi-
cal diagnosis was defined as the total diagnostic delay. In order to limit the re-
call bias inherent to this kind of studies, delay data collected from the patient 
was also validated by those obtained from close relatives. In both situations, 
identical structured interviews were undertaken for all cases. The median of 
total diagnostic times has been used as a cut-off point to distinguish between 
delayed and non-delayed cases in a more objective way.
TNM stage was considered as the dependent variable  (early = tumour-
node-metastasis [TNM] stage I or II; advanced = TNM stage III or IV). Early 
stages include a variety of tumour sizes (<4 cm) without invasion of adjacent 
structures, and no lymph node or distant metastases. Advanced stages include 
tumours invading adjacent structures, e.g., through cortical bone, into deep 
(extrinsic) muscle of tongue, maxillary sinus, and skin, or a more advanced 
node status than early stages’ or display distant metastases (15). 
Statistical analysis
Data were entered on the PASW statics18 statistical package and the sample 
characterized by the variables of interest. A descriptive study was conducted 
where quantitative variables were expressed as mean ± standard deviation; 
and qualitative ones as absolute frequency and percentage.  
Means were compared using the Student’s t test after assessing their nor-
mality with the kolmogorov-Smirnov test. Those variables that are clinically 
relevant or were significantly related to advanced TNM-stage after univariate 
analysis (simple logistic regression) were included in a multivariate  model 
(multiple logistic regression). The significance level chosen for all tests was p<0.05.
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Results
A total of 88 patients (mean age 60±11.3), mostly males (65.9%) entered the 
study. The most frequent tumour sites were tongue (36.4%), floor of the mouth 
(27.3%) and gingivae (17%).
The median for the interval between the first sign/symptom to patho-
logical diagnosis was 45 days, and most patients (54.5%) suffered no delayed 
diagnosis. A 45.5% of the oral carcinomas were diagnosed at early stages (I-
II). The most frequent clinical lesions were ulcers (70.5%), being the cancer 
associated to a precancerous lesion in a 16.5% of the cases. 
Most cases were well- and moderately-differentiated (91%) (Table 1). 
Univariate analyses revealed that age  (OR=1.0; 95%CI=0.9-1.0), smoking 
habit (OR=1.4; 95%CI=0.5-3.9), alcohol usage (OR=1.0; 95%CI=0.4-2.6 ), co-
existence of a precancerous lesion (OR=0.6; 95%CI=0.2-2.1) and the clinical 
presentation (ulcerated/mixed) of the oral carcinoma (OR=2.7; 95%CI=0.7-
9.9) were neither significantly associated to diagnosis at advanced-stages, nor 
to TNM-advanced stage (OR=0.7; 95%CI=0.3-1.6).
On the other hand, male gender was identified as a risk factor for late TNM 
stage at diagnosis (OR=3.8; 95%CI=1.4-9.6). Strong associations between 
advanced stages and moderate-poor differentiation (OR=4.2; 95%CI=1.6-
10.9) or tumour site (floor of the mouth (OR=3.6; 95%CI=1.2-11.1); gingivae 
(OR=8.8; 95%CI=2.0-38.2); and retromolar trigone (OR=8.8; 95%CI=1.5-
49.1)) have also been identified by univariate analysis (Table 2)
Regression analysis excluded “gender” from the multivariate model, re-
maining tumour site and degree of differentiation significantly associated to 
high risk of late-stage diagnosis (Table 3).
Discussion
The current recommendations to screen for oral cancer at every routine 
check-up is not practical and has not produced the intended results. Selective 
opportunistic screening may be a more realistic and effective solution. Detec-
tion of oral and oropharyngeal SCCs during a non-symptom-driven examina-
tion has proved an association to lower stage at diagnosis, in the same way as 
patients with a regular primary care dentist are significantly more likely to be 
diagnosed at early stages (4, 16).
Unfortunately, about a 60% of cancers are identified late (stages III or IV) 
with survival rates ranging from 10% to 40% after 5 years (17, 18). Up to a 
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54.5% of the patients in this series were diagnosed at late stages, and recogni-
tion of predictors for advanced-stage diagnosis could permit the development 
of strategies aimed at improving this percentage.
Age, gender, and tobacco and alcohol consumption did not behaved as 
variables linked to late-stage diagnosis; as were not previously associated to 
professional or patient-related diagnostic delays (19, 20). The existence of 
precancerous lesions associated to the tumour did not seem to modify the 
extension of the disease at the moment of diagnosis, despite that proliferative 
verrucous leukoplakia or the presence of mild or moderate epithelial dysplasia 
at the margins of a surgically removed OSCC carries a significant risk of local 
recurrence and modifying prognosis (21).
Ulcerated-type OSCC were diagnosed mostly (up to a 60%) at stages III-
IV, but this association did not reach statistical signification. Moreover, the 
predictive value for survival of the lesion clinical appearance is controversial, 
although it is accepted that ulcerated lesions imply poorer survival rates (22).
Previous reports have described the association between primary tumour 
site and delayed diagnosis or diagnosis at advanced stages (23): tongue, buccal 
mucosa and lip have been recognised as locations that favour early-stage di-
agnosis (18), whereas the floor of the mouth and the retromolar trigone have 
been linked to diagnosis at advanced stages; locations like palate or gingivae 
showed contradictory results (18, 24). Our data show that the floor of the 
mouth, gingivae and retromolar trigone behaved as an independent prognos-
tic factor for late stage at diagnosis. These findings may well be explained by 
the fact that patient’s self-perception and self-exploration abilities depend on 
the site of the tumour (25), and also because gingival locations are associated 
to advanced stages at diagnosis (late diagnosis) due to the early invasion of the 
adjacent tissue (T4 primary tumour) (26).
Advanced-stage diagnosis in oral cancer has traditionally been attrib-
uted to delays in reaching a diagnosis, as patients at advance tumour stages 
are more likely to have longer patient and professional delays than those at 
early stages (27). However, the lack of sound scientific evidence supporting 
the existence of an association between diagnostic delay, extent of the disease 
(III-IV TNM stages) and lower survival rates is evident (12-14). This fact is 
probably related to a series of limitations and methodological flaws identified 
in the published reports to date, mainly related to heterogeneity in both the 
definition and measurement of diagnostic delay, the retrospective nature of 
these studies and also to a memory bias of the patients (12,13).
In this study, diagnostic delay was not significantly linked to advanced 
stage at diagnosis; thus the quickness in obtaining a diagnosis does note guar-
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antee an early-stage tumour, although delay in the diagnosis of a neoplasm is 
universally considered unacceptable.
On the other hand, poor differentiation of the tumour (biologically more 
aggressive) behaved as an independent risk factor for diagnosis at stages III-
IV. The tumour growth rate may play the role of a confounding factor in the 
relationship between diagnostic delay and disease-stage or survival, as patients 
with aggressive tumours and bad prognosis do not usually present diagnos-
tic delay whereas tumours with low proliferation rates elicit good prognosis 
despite  long diagnostic delays (28). Unfortunately, the evidence on tumour 
proliferation activity that could corroborate this hypothesis is scarce.
This paradoxical circumstance has previously been described  in breast, 
cervix, lung, colon, renal, and urethral cancers and seems to suggest that 
stage at diagnosis is affected more by the biology of the cancer (rapid tumour 
growth) than by diagnostic delay (28,29). These results seem to suggest that 
the stage of oral cancer at the time of diagnosis is affected more by the biology 
of the cancer (degree of differentiation) than by diagnostic delay.
Taking into account that early diagnosis is a foremost step for reducing 
cancer mortality, it is concluded that the efforts aimed at early diagnosis or oral 
cancer should be prioritized towards screening programmes designed to detect 
the disease during its asymptomatic phases. Educational interventions on the 
population, particularly focused on risk groups (self-exploration) and on the 
professionals (clinician’s index of suspicion) should include a sound knowledge 
of the disease presentation, specifically on sites like floor of the mouth, gingivae 
and retromolar trigone. More studies are needed in order to analyse the part of 
tumour biology on the extension of the disease at the time of diagnosis.
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Table 1. Description of the sample (n=88).
Variables Mean SD Minimum-Maximum
Age 60.3 11.3 38.8 88,1
n % 95% CI
Gender
Female
Male
30
58
34.1
65.9
23.6-44.5
55.4-76.3
Smoking
Non-Smoker
Former-Smoker
Current-Smoker
22
16
43
27.2
19.7
53.0
16.8-37.4
10.4-29.0
41.6-64.5
Alcohol usage
Non drinker
Drinker
51
27
65.4
34.6
54.1-76.5
23.4-45.8
Tumour site
Tongue
Floor of the mouth
Gingivae
Buccal Mucosa
Retromolar trigone
Hard palate
32
24
15
  5
10
  2
36.4
27.3
17.0
  5.7
11.4
  2.3
25.7-46.9
17.3-37.1
  8.6-25.4
  1.8-12.7
  4.1-18.5
  0.2-7.9
TNM Stage
Stage I
Stage II
Stage III
Stage IV
10
30
14
34
11.4
34.1
15.9
38.6
  4.1-18.5
23.6-44.5
  7.6-24.1
27.8-49.3
Tumour size
T1
T2
T3
T4
12
43
10
23
13.6
48.9
11.4
26.1
  5.8-21.3
37.8-59.8
  4.1-18.5
16.3-35.8
Neck node status
Negative (N0)
Positive(N1,2,3)
61
27
69.3
30.7
59.1-79.5
20.4-40.8
Macroscopic features
Exophytic
Mixed
Ulcerated
12
11
55
15.3
14.1
70.5
  6.7-24.0
  5.7-22.4
59.7-81.2
Degree of differentia-
tion
Well
Moderate
Poor
29
51
  7
33.0
58.0
  8.0
22.8-43.8
47.6-69.5
  1.7-14.3
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Table 2.  Patient characteristics distribution according to TNM-
stage at diagnosis. Simple logistic regression analysis. 
Variables 
Early stage 
(I-II)
n=40 (45.5%)
Advanced stage (III-
IV) n=48(54.5%) p-value
Odds Ratio 
(95%CI)
Age (yrs)
Mean ±SD 59.4±11.0 61.1± 11.6 0.5 1.0 (0.9-1.0)
Gender
Female
Male
20 (66.7)
20 (34.5)
10 (33.3)
38 (65.5) 0.005
1.0 (Referent)
3.8 (1.4-9.6)
Tobacco use
Non-smoker
Smoker
11 (50.0)
24 (40.7)
11 (50.0)
35 (59.3) 0.4
1.0 (Referent)
1.4 (0.5-3.9)
Alcohol Use
Non-drinker
Drinker
12 (44.4)
22 (43.1)
15 (55.6)
29 (56.9) 0.9
1.0 (Referent)
1.0 (0.4-2.6)
Associated precan-
cerous lesion 
No
Yes 28 (43.1)7 (53.8)
37 (56.9)
6 (46.2) 0.5
1.0(Referent)
0.6 (0.2-2.1)
Macroscopic fea-
tures
Exophytic
Mixed+Ulcerated
8 (66.7)
28 (42.4)
4 (33.3)
38 (57.6) 0.1
(Referent)
2.7 (0.7-9.9)
location
Tongue
Floor of the mouth
Gingivae
Buccal mucosa
Retromolar trigone
Hard palate
22 (68.8)
9 (37.5)
3 (20.0)
3 (60.0)
2 (20.0)
1 (50.0)
10 (31.1)
15 (62.5)
12 (80.0)
2 (40.0)
8 (80.0)
1 (50.0)
0.02
0.004
0.7
0.01
0.6
(Referent)
3.6 (1.2-11.1)
8.8 (2.0-38.2)
1.4 (0.2-10.1)
8.8 (1.5-49.1)
2.2 (0.1-38.8)
Diagnostic delay
No
Yes
20 (41.7)
20 (50.0)
28 (58.3)
20 (50.0) 0.4
1.0(Referent)
0.7 (0.3-1.6)
Degree of differen-
tiation 
Well
Moderate
Poor
20 (69.0)
19 (37.3)
1 (14.3)
9 (31.0)
32 (62.7)
6 (85.7)
0.008
0.02
(Referent)
3.7 (1.4-9.8)
13.3 (1.3-127.5)
88 FACTORS RELATED TO LATE STAGE DIAGNOSIS
Table 3. Multiple logistic regression analysis of the association 
between advanced staged and patients/tumours characteristics.
Characteristics B S.E. Wald p-value Odds Ratio (95%CI)
Constant -2.88 0.7 14.4 0.000 0.056
Gender
Female
Male 0.98 0.58 2.82 0.09 2.6 (0.8-8.4)
location of the tumour
Tongue
Floor of the mouth
Other
1.57
2.37
0.71
0.68
4.8
11.9
0.028
0.001
4.8 (1.1-19.5)
10.7 (2.8-41.3)
Degree of differentiation
Well
Moderate
Poor
1.32
4.11
0.58
1.30
5.2
9.9
0.022
0.002
3.7 (1.2-11.7)
61.1 (4.7-786.7)
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Summary
Little is known on educational strategies in cancer control. Continuing Medi-
cal Education (CME) has a large impact on oral cancer attitudes, knowledge, 
and behavior. Reading scientific journals is a key component of CME. The 
objective of this study was to assess preventive and clinical attitudes of the 
participants in an educative intervention in oral cancer based on scientific 
journals.
The study consisted of a cross-sectional study performed on online us-
ers of the Spanish Board of Dentists and Stomatologists, using an anony-
mous, self-applied questionnaire. We asked 791 general Dental Practitioners 
(gDPs) to participate in the study. The large majority claimed that they de-
liver tobacco-cessation counseling (93.6%), as well as advice on alcohol con-
sumption (66.6%) while advice on vegetable intake was less frequently pro-
vided (42.4%). 
Alcohol intake advice, routine mucosa exploration and biopsy perfor-
mance on lesions suspicious of malignancy are preventive attitudes related 
to training. Compared with those who did not benefit from CME courses 
or did so only once, the gDP’s who received 4 or more CME courses show a 
doubling in the odds of giving alcohol advice to their patients, a ten-fold in-
creased odds of performing mucosa check on a routine basis and are 3.5 times 
as likely to take biopsies of suspicious lesions. A longer experience as a gDP 
does not increase the probability of adopting preventive attitudes. 
In addition to the presentation of the results of our study, we also discuss 
in a less specific fashion the usefulness of other preventive measures in oral 
cancer 
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introduction
Oral and pharyngeal cancer represent the sixth leading cancer in the world 
and rank in the top three cancers in high incident areas.1 Furthermore, oral 
cancer with a worldwide incidence of 3.8 cases per 100,000 person-years and 
a mortality rate of 1.9 cases per 100,000 person-years, accounts for 1.68% 
of all cancer deaths, based on data reported by the International Agency for 
Research Cancer (IARC, WHO, 2010).2 This disorder is the seventh most 
prevalent malignancy in Europe (IARC, WHO, 2004).1,3 Survival remains 
unaffected despite recent therapeutic advances,1-4 mainly due to delay in the 
diagnosis.4,5 However, if these malignancies were diagnosed and treated at 
early stages survival rates would probably exceed 80% .5
Professional diagnostic delay is strongly related to tumor stage at the time 
of diagnosis.6 Determinants of professional diagnostic delay include lack of 
knowledge on oral cancer, lack of experience in the disease, absence of full 
clinical examination and presence of co-morbidity.7,8
Dentists play a critical role in the early diagnosis of oral cancer5. Sev-
eral authors have identified specific training in medical graduates and dental 
students as a key issue to reduce the burden of oral cancer through effective 
cancer control strategies. These strategies include advice on reducing tobacco 
consumption, promotion of healthier diet and lifestyle and, most importantly, 
early detection through screening examinations and adequate follow-up.9-16 
It is then of paramount importance to develop appropriate initiatives to in-
crease knowledge and favor preventive attitudes both at university and profes-
sional level, using Continuing Medical Education (CME) in the latter.17
CME courses exert a positive influence on oral cancer attitudes, knowl-
edge, and behavior of the attendees, which is a key issue in oral cancer con-
trol.5,18 Reading scientific journals is a key component of the CME.19-22 
In this regard, dental professional organizations in the USA (American Den-
tal Association) and Europe (British Dental Association) have implemented 
CME initiatives aimed at providing training on new treatments, last research 
advances and business practices, using their newsletters or journals. However, 
we are not aware of any oral cancer-related CME effort using scientific jour-
nals aimed at gDPs. 
The Spanish Board of Dentists and Stomatologists (SBDE, in Spanish: 
COE) has recently carried out a pilot experience in continuous education in 
oral cancer by means of scientific journals. The objective of this study was to 
assess preventive and clinical attitudes related to oral cancer among gDPs.
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Methods 
We carried out a cross-sectional study between January and December 2009 
among gDPs affiliated with the SBDE (affiliation is compulsory for dental 
practice) who accessed an online Continuous Education program based on 
the journal of the Board (RCOE: Revista del Consejo de Odontólogos y Es-
tomatólogos), a journal that is distributed to or freely accessed every trimester 
by the 25000 members of the Board.  
As a special collaboration with our study, RCOE published in April 2009 
a monograph on oral cancer, written by a panel of experts, which focused on 
early detection of lesions suspicious of malignancy.23 A customized platform 
was designed to host an anonymous and confidential self-administered ques-
tionnaire designed for our study, as well as an online exam on the content of 
the monograph that had to be submitted to the accreditation board in order 
to pass the CME course.    
The questionnaire was a modified version of previous survey instru-
ments.14-15 To ensure feasibility, we carried out a pilot study among a small 
sample of the participants. The questions were broadly grouped into three 
sections: gDPs profiling questions (demography and practice), questions on 
preventive attitudes towards oral cancer, and specific questions about clinical 
practice oriented towards early detection (systematic examination of the oral 
cavity and biopsy of suspicious oral lesions).
Ethical approval was granted by the Bioethical Committee of the Univer-
sity of Santiago de Compostela.
Statistical analysis
Statistical analysis was performed using SPSS+ 11.0 statistical package (Chica-
go, IL, USA). To determine which factors were related to preventive attitudes, 
we used a multiple logistic regression analysis to obtain odds ratios (OR) and 
their 95% Confidence Intervals (95%CI). The outcome is one of the following 
preventive attitudes: anti-tobacco advice, alcohol advice, fruit intake advice, 
routine mucosa check or  biopsy performance, and the exposure variables are 
those related to training, such as the number of CME courses or the amount of 
professional experience. The estimates were adjusted by age, sex and the rest 
of the exposure variables. Hence, each of our OR estimates is free of potential 
confounding due to personal variables or to other variables related to training. 
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Results
Our study population was formed by 791 gDPs with a mean age of 35 ± 9.6 
years, mostly females (61.7%), more than one-third of whom had 10 years 
or more of practice. About one-fourth of the participants acknowledged that 
their only postgraduate training on oral cancer was reading the monographic 
issue of the newsletter used in this study, while 36.3% had attended more than 
two courses on oral malignancies. Table 1 summarizes the distribution of key 
variables in the study population. The large majority (93.6%) delivers anti-
tobacco advice to their patients and two-thirds advise their patients to reduce 
alcohol intake. However, only 42% recommend their patients to have an ad-
equate intake of fruit and vegetables. As for routine clinical attitude, 90.3% 
check their patients’ oral mucosa but only 29% perform biopsy on suspicious 
oral lesions.
From multivariate analysis (Table 2) we observe that no variable is signif-
icantly related to anti-tobacco advice delivery. This means that advice is given 
independently of the background or training of the gDPs. We also observe 
that recommendations on fruit intake are significantly more frequent among 
older gDP’s, but no other factor, especially those in connection with training, 
is related to this preventive attitude. Alcohol intake advice, routine mucosa 
exploration and biopsy performance on lesions suspicious of malignancy are 
preventive attitudes related to training factors. Compared to those who did 
not benefit from CME courses or did so only once, the gDP’s who received 
4 or more CME courses show a doubling in the odds of giving alcohol advice 
to their patients, a ten-fold increased odds of performing mucosa check on 
a routine basis. They are 3.5 times as likely to take biopsies of suspicious le-
sions and twice as likely to give alcohol advice to their patients. Also, those 
who received 2 to 3 CME courses double their odds of performing mucosa 
check. Having received specific oral cancer courses increases by 50% the like-
lihood of performing biopsies when indicated. Finally, a longer experience as 
a gDP (measured by years of practice in the field) does not seem to increase 
the probability of adopting preventive attitudes. On the contrary, experienced 
doctors are less likely to take biopsies. However, older gDP’s do perform more 
biopsies on suspicious lesions.
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Discussion
Whereas continuous dental education is compulsory in the USA, this require-
ment is not uniform in European countries, where, in general, it is considered 
as a moral duty for the dentist. Nowadays several countries including Austria, 
Cyprus, Estonia, Finland, The Netherlands, Norway, Sweden and Spain main-
tain a voluntary scheme for their CME system.24 Therefore, the results of our 
study cannot compare directly to those countries where CME is mandatory 
for dentists. 
Our results show that CME courses are useful to increase gDP’s pre-
ventive attitudes, especially those related to clinical practice (routine mucosa 
exploration and biopsy performance). Specific courses are useful to increase 
biopsy taking but do not seem to improve other preventive attitudes. The 
paradoxical association between the decrease in mucosal exam and biopsy 
taking as years in practice increase, could well be explained by the fact that 
less experienced gDPs (<10 years) have benefited from improved continuous 
education schemes and have received undergraduate training entirely at den-
tal schools. Similar findings have been reported from Italy, where the school 
of graduation (dental school vs. medical school) seems to influence these pre-
ventive practices. 18
Our study is limited by the fact that it is a cross-sectional study based on 
a convenience sample. In particular, the main disadvantage of this design is 
that it does not allow for proper causal inference as exposure and outcome are 
measured at the same time and temporality is not firmly established. How-
ever, this type of studies has proved useful for health services management 
to improve clinical practice and to identify educational problems. There is 
potential for selection bias in our data due the absence of randomization of 
the participants. However, the population of our study is representative of the 
Spanish general population of gDP’s as far as it concerns age, years of profes-
sional experience, geographic distribution and preventive attitudes towards 
oral cancer.15 
Confounding by other variable cannot explain our results. We have ad-
justed our results by those factors that may be related with the outcome and 
with the main exposure (preventive attitudes and training). The relative risk 
estimates are robust to this adjustment. However, as in any observational 
study, we cannot rule out the presence of residual confounding due to un-
known or unmeasured variables. 
Prevention frequently offers the most cost-effective strategy for cancer 
control.29,30  Despite the fact that advice on smoking cessation, alcohol in-
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take moderation and healthy eating is an essential and ethical part of the den-
tist’s role, several gaps in knowledge were described previously. 31
Regarding smoking, previous studies show a significant reduction in the 
risk of oral cancer among quitters, which approximates that of never smokers 
approximately 10 years after cessation.32 Our results show that a high propor-
tion of gDPs report using their position to advice patients on tobacco cessa-
tion. A similar proportion was reported in the Uk .33
Alcohol consumption is considered excessive when it exceeds an average 
of one (for females) or two (for males) drinks per day.34 Recommendations 
to reduce alcohol intake have the potentiality of reducing the incidence of 
oral cancer and oral premalignant lesions in non-smokers and smokers alike. 
However, only two-thirds of our population advised on alcohol consumption. 
Contrary to earlier impressions, it has been shown that patients do accept al-
cohol screening and alcohol counseling by the dentist. 35
Regardless of the existence of studies that support the beneficial effects 
of high intake of vegetables and fruits on the risk of developing cancers of the 
oral cavity and on reducing recurrences and mortality (overall and specific),36 
the lower consumption of fruits and vegetables constitutes the less known risk 
factor for oral cancer both in Europe and the USA,9-16 as confirmed by our 
results, with only 42.4% of the participants providing dietary recommenda-
tions (5 serves per day) to prevent this disease. 
Educational aspects
Reading scientific journals is an accepted method of continuous scientific 
training. There is now a growing awareness of the need of any clinician to 
devote a certain amount of time to this activity.25,26,27 
Some authors have shown that clinicians favor enrolment in educational 
courses over reading activities to achieve CME credits, both in compulsory and 
voluntary schemes. 19-21 However, when dealing with oral pathology, some 
surveys report journal reading to be the preferred continuing education activ-
ity by practitioners. Furthermore, dentists who read about oral cancer refer 
fewer difficulties in achieving a diagnosis of potentially malignant lesions.28 
Our results show that one-fourth of the participants received information on 
oral cancer, for the first time since graduation, through reading activities. It is 
then important to promote strategies to increase reading activities. 
Secondary prevention-related practices
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Early diagnosis is critically essential and may have a dramatic impact on 
survival and curation.7,8 The standard diagnosis relies on detection during 
visual examination followed by tissue biopsy for histopathological diagnosis.5 
However, other techniques may prove useful as complementary tools such as 
light-based detection systems,; speciﬁc blood tests (CEA, SCCAA, IAP, Cy-
FRA, ANXA1 and others); speciﬁc saliva tests, and imaging.37
Opportunistic screening (offering patients a screening test when they at-
tend a clinic for some other unrelated reason) may be cost-effective particu-
larly in general dental practice.38 However, including high-risk groups in this 
screening is not feasible as these groups do not attend dental practice on a 
regular basis.39 Selective opportunistic high-risk screening may be a more 
realistic and effective solution for areas with low incidence of oral cancer.40
When dealing with smokers or excessive alcohol consumers, it is advis-
able for the clinician to remain alert for signs of potentially malignant lesions 
or early-stage cancer during visual and tactile exploration of all patients.45
Most respondents (90.3%) declared to perform a systematic explora-
tion of oral soft tissues to rule out oral cancer. This proportion is close to that 
found in former studies in Europe and the USA (83-86%) 41-42 but signifi-
cantly higher than that described in a representative sample of Spanish gDPs 
(81.5%).15
The proportion of gDPs who perform biopsy tests is low in spite of exist-
ing recommendations.43 The number of primary care dentists who offer oral 
biopsy, either on a routine or on a selective basis, is scarce in Europe (12% in 
Northern Ireland;44 21% in Uk45) probably due to the lack of specific train-
ing. However, recent reports show that this proportion is increasing.15,18 The 
fact that, in our study, men perform biopsies more frequently than women 
was already described in a former study. 46
From our study, we conclude that gDPs attending CME oral cancer 
courses show positive preventive attitudes in oral cancer, especially towards 
delivering counseling on alcohol consumption and performing routine explo-
ration of the oral mucosa and biopsy. Reading scientific journals is the corner-
stone of CME. Oral cancer prevention and detection should be periodically 
included in dental newsletters and journals.  
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8. fUTURE lINES Of INvESTIGATION 
Unfortunately, in the early detection of oral cancer studies, the variable “out-
come” of late diagnosis is poorly defined, and the multiple authors use several 
different criteria and conceptual frame. Because of this, the different temporal 
sections that make the interval between the first body changes associated with 
the tumour and the treatment start date should be investigated. It should also 
be checked the clinical applicability of the “Aarhus Statement” in the different 
socio-cultural context.
Conversely, several research groups have studied the concept of delay in 
diagnosis of oral cancer, but using heterogeneous criteria such as different 
types of data collected (eg: continuous variables versus categorical, or diverse 
sources of information on patient delay (standard questionnaires, interviews, 
hospital records, etc.) than may –along with variations in tumour biology- 
explain the absence of a consistent relationship between diagnosis delay and 
stage at diagnosis in the literature. Despite these shortcomings, diagnostic de-
lay has recently been relater to a worse survival rate in head and neck cancers3.
However, and due to the reported absence of an adequate conceptual 
frame for studying diagnostic delay in other tumours of the human body 
(little consistency of definitions of delay, different ways of measuring delays, 
and difficulties in comparing cancers with different biological behaviour), a 
guideline –The Aarhus Statement- has been proposed to improve the design 
and reporting studies on early cancer diagnosis4. This guideline recommends 
the substitution of the term “delay” (eg: “patient delay”) by “intervals” or “time 
intervals”. The aforementioned statement also suggests key time points (date 
of first symptom, date of first presentation, date of referral and date of diagno-
sis) and time intervals.
It is particularly relevant for gDPs the “date of first presentation” (time 
point at which, given the presenting signs, symptoms, history and other risk 
factors, it would be at least possible for the clinician seeing the patient to have 
started investigation or referral), and the date of referral (time at which there 
is a transfer of responsibility from one health care provider to another). This 
time period could be shortened using training as part of CPD for all members 
of the dental team1, and a variety of additional approaches.
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9. DISCUSSION
Many has been written on early diagnosis of oral cancer and much will be 
written as secondary prevention not only eases treatment but it is also widely 
reported to influence survival. However, when dealing with early diagnosis 
the question of when to consider a diagnosis delayed arises and then time-
points become particularly important. Ideally, a non-delayed diagnosis (per-
fect early diagnosis) should be performed at the time of the cancer onset (at 
the very beginning of the preclinical phase), which is, obviously, not feasible. 
In turn, reports on this topic focus on the clinical phase of the disease and 
use the inception of signs and symptoms as the zero point to their researches. 
This approach is limited by an evident lack of precision, particularly when 
the sign/symptom onset is frequently retrospectively identified by the patient 
and, thus, prone to a recall bias. Conversely, it is a somehow identifiable time-
point (although with a wide range of error tolerance) that can be used in dif-
ferent settings and permits investigations on this field which would not be 
possible otherwise.
Using the sign/symptom inception as a reference implies additional 
shortcomings, as not all areas of the oral cavity are equally accessible for self-
exploration and similar lesions produce different symptoms in different oral 
sites (Wildt et al, 1995; O’Sullivan 2001; Tromp et al 2005), so some cancers 
may be more easily detected than others, which would be more prone to a late 
diagnosis due to this particularity. At this stage, some attention has to be paid 
to the psychosocial characteristics of the patient, who has to identify these 
sign/symptoms as abnormal and has to decide whether professional help is 
required for his/her problem. This decision will undeniably influence the time 
of diagnosis (kumar et al 2001).
The mere idea of diagnostic delay entails that some time is needed to 
reach a diagnosis, so only cancers diagnosed beyond that time-frame could 
be considered delayed. This concept introduces more variability in research 
on this topic, as the time required to diagnose an oral neoplasm is not specifi-
cally defined in the literature and it is conditioned by a wide range of agents 
and situations (gómez et al, 2010). This fact adds to the already mentioned 
limitations at identifying the initial event that defines the time lapse. In this 
sense, many research groups have used the mean or the median of the time 
distribution (considered since the sign/symptom onset to definitive diagno-
sis) to distinguish between non-delayed and delayed cases (those beyond the 
mean or the median); the median is more frequently used because it is not af-
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fected by extreme values and these distributions usually have very wide ranges 
(Stroup et al, 2000).
As a result of the vagueness in the definition of the limits of the concept 
of diagnostic delay in oral cancer, the existing investigations do not always use 
homogeneous criteria (yu et al, 2008; gómez et al, 2009; gómez et al, 2010) 
and thus comparative analysis are not always possible. However, it seems rea-
sonable to assume that a cancer’s stage at diagnosis is a function of the length 
of time it has been developing prior to diagnosis. Then, the longer the delay, 
the more advanced the disease would be and a worse prognosis should be ex-
pected (Mcgurk et al, 2005) but, although oral cancer main features (tumour 
size and nodal status) appear to correlate well with tumour growth chronol-
ogy (Brown et al, 1989; Parker et al, 1996), many studies either failed to prove 
this association (guggenheimer et al, 1989; Dimitroulis et al 1991; kowalski 
et al 1994; gorsky & Dayan, 1995; Wildt et al, 1995; Amir et al, 1999; Pitiphat 
et al, 2002; kerdpon & Sriplung, 2001; Onizawa et al, 2003), or demonstrat-
ed and inverse relationship (shorter delays linked to more advanced stages) 
(Carvalho et al, 2002). 
Theoretical tumour growth assumes no treatment and no cell lost, but 
cell loss increases when a tumour grows and outstrips its blood supply. Neo-
plasms typically grow progressively, but even with a single tumour type there 
are significant variations that lead to unpredictable differences in the pattern, 
speed of onset, and progression of patient symptoms than would definitively 
condition the moment of diagnosis (Neal, 2009). Studies involving tumours of 
different locations also distort this apparent relationship between diagnostic 
delay and tumour stage, as occurs with gingival locations which are associated 
advanced stages at diagnosis due to the early invasion of the adjacent bony 
tissue (T4 primary tumour), yet could present without time delay (Seoane et 
al, 2006).
Different velocities of tumour growth may well also explain why some tu-
mours remain small in size in spite of delay. Even though some studies linked 
diagnostic delay and advanced tumour stage, it is possible that the relation-
ship between delay and advanced tumour stage, it is possible that the relation-
ship between delay and advanced tumour stage is veiled by the fact that cer-
tain cancers remain silent during the initial stage and induce symptoms only 
when they reach and advanced phase (silent tumour hypothesis) (Scott et al, 
2005). This being, the tumour growth rate would act as a confounding factor 
in the relationship between diagnostic delay and tumour stage since patients 
with aggressive tumours and poor prognosis do not usually present diagnostic 
delay, while tumours with low proliferation rates demonstrate good prognosis 
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despite long diagnostic delays (kaufmann 1980; Evans, 1982). In this sense, 
reports on tongue cancer are particularly interesting (kantola et al, 2001; 
Teppo & Alho, 2008) because the impact of diagnostic delays on survival is 
apparently unreasonable: shorter delays impaired survival. This paradoxical 
circumstance, where diagnostic delay, tumour stage and tumour prognosis are 
inversely related, has been previously described in endometrial, cervix, lung, 
colon, renal and urethral cancer, and seems to suggest that stage at diagnosis 
and survival are strongly affected by the biological aggressiveness of the can-
cer (Crawford et al 2002; Neal 2009; gómez et al, 2010).
Oral cancer is a relatively proliferating tumour with proven heteroge-
neity in its biological behaviour. Specifically HPV negative, aneuploid and 
TP53-mutated tumours have shown less favourable prognoses (Leemans et 
al, 2010). Moreover, the expression of different oncogenic markers including 
, p16, p21, p27, MDM2, MgMT, EgFR, ERBB2, RARB, MyC, BCR-ABL1, 
RAS, CCND1, STAT-3, and VEgF, induce a more rapid clinical course (da 
Silva et al, 2011) that considerably reduces the opportunities for a diagnosis 
at early stages of the disease. Alternatively, HPV positive oral cancers, mostly 
oropharyx, mainly wild-type TP-53 have demonstrated favourable prognosis 
(Leemans et al 2010).
The lack of sound scientific evidence supporting the traditional associa-
tion between diagnostic delay and disease extension, together with the wide 
variability in the biological behaviour induced by different genetic profiles, 
may justify the hypothesis that biological heterogeneity may be more relevant 
than diagnostic delay in oral cancer. The corroboration of this hypothesis 
would have important implications in oral cancer and precancer screening 
strategies, reinforcing opportunistic screening in at-risk populations (as rap-
idly growing tumours –where the quickness in obtaining a diagnosis does not 
guarantee an early stage- have short periods for a potential screening, whereas 
slowly growing tumours permit a longer screening period).
In order to disentangle this apparently contradictory information, the 
second part of our investigation used meta-analytical tools on the existing 
literature on this topic. The initial systematic search identified 1016 relevant 
papers published since 1966, which were reduced to 10 after a more detailed 
review. This fact is a reflection of the heterogeneous criteria employed by the 
different research groups and frequent methodological flaws that impairs re-
search in this field.
globally, the results of this meta-analysis showed that diagnostic delay is 
moderately related to mortality of head and neck cancers. The association was 
stronger for pharynx cancer, a fact that may be due to the rapidity at which 
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pharyngeal cancers metastasize (Brouha et al 2005). Part of this observed ef-
fect may be caused by residual confounding, distortion due to incomplete 
adjustment for variables that could potentially alter the relationship between 
delay and mortality. Sex is one of those variables, as some studies included 
in our meta-analysis did not provide relative risk estimates adjusted for sex, 
and the pooled effect for sex adjusted studies was much smaller than that of 
unadjusted studies. The biological behaviour of the tumour is another of those 
variables, which was considered only by one of the studies included in our 
investigation (Seoane et al, 2010).
The already mentioned relationship between tumour site and perception 
of the symptoms and identification of the clinical signs may explain the dif-
ferent magnitudes of association observed between delay and survival in the 
meta-analytical study: our results show a strong association between the ex-
istence of diagnostic delay and worse survival to pharyngeal carcinomas. It is 
remarkable that most of these pharyngeal cancers were diagnosed at very ad-
vanced stages of the disease (stage IV) (koivunen et al 2001; Ho et al 2004). On 
the contrary, the effect of diagnostic delay on mortality could not be proved 
for oral carcinomas, probably because 2 out of 4 studies considered restricted 
their analysis to tongue tumours (kantola et al 2001), and existing reports on 
tongue cancers are particularly contradictory, as referral delays worsen sur-
vival (kantola et al 2001), but professional delays do not (Sandoval et al 2009).
Taking into account the results obtained from the meta-analytical ap-
proach to the problem of the relationship between diagnostic delay and tu-
mour stage and survival to oral cancer, the next step of this investigation had 
to be an ambispective cohort study on incident cancer patients. The study 
sample was made of 88 oral cancer patients whose lesions were unevenly dis-
tributed within the oral cavity: buccal mucosa (n=5), upper and lower gin-
gival (n=15), hard palate (n=2), tongue (n=32), floor of the mouth (n=24) 
and retromolar trigone (n=10). To calculate diagnostic delay, and in order to 
diminish the recall bias inherent to this kind of studies, delay data collected 
from the patient was also validated by those obtained from close relatives. In 
both situations, identical structured interviews were undertaken for all cases.
Previous reports have described the association between primary tumour 
site and delayed diagnosis or diagnosis at advanced stages (Brouha et al, 2005)): 
tongue, buccal mucosa and lip have been recognised as locations that favour 
early-stage diagnosis (gorsky & Dayan, 1995), whereas the floor of the mouth 
and the retromolar trigone have been linked to diagnosis at advanced stages; 
locations like palate or gingivae showed contradictory results (gorsky & Dayan, 
1995; Morelatto et al, 2007). Our data show that the floor of the mouth, gingivae 
115DISCUSSION
and retromolar trigone behaved as an independent prognostic factor for late 
stage at diagnosis. These findings may well be explained by the fact that patient’s 
self-perception and self-exploration abilities depend on the site of the tumour 
(Andersen & Cacioppo, 1995), and also because gingival locations are associ-
ated to advanced stages at diagnosis (late diagnosis) due to the early invasion of 
the adjacent tissue (T4 primary tumour) (Seoane et al 2006).
Advanced-stage diagnosis in oral cancer has traditionally been attributed 
to delays in reaching a diagnosis, as patients at advance tumour stages are 
more likely to have longer patient and professional delays than those at early 
stages (Sargeran et al, 2009). However, the lack of sound scientific evidence 
supporting the existence of an association between diagnostic delay, extent of 
the disease (III-IV TNM stages) and lower survival rates is evident (gómez 
et al 2009; gómez et al 2010; goy et al 2009). This fact is probably related to a 
series of limitations and methodological flaws identified in the published re-
ports to date, mainly related to heterogeneity in both the definition and mea-
surement of diagnostic delay, the retrospective nature of these studies and also 
to a memory bias of the patients (gómez et al 2009; gómez et al 2010).
In this study, diagnostic delay was not significantly linked to advanced 
stage at diagnosis; thus the quickness in obtaining a diagnosis does note guar-
antee an early-stage tumour, although delay in the diagnosis of a neoplasm is 
universally considered unacceptable.
On the other hand, poor differentiation of the tumour (biologically more 
aggressive) behaved as an independent risk factor for diagnosis at stages III-IV. 
The tumour growth rate may play the role of a confounding factor in the rela-
tionship between diagnostic delay and disease-stage or survival, as patients with 
aggressive tumours and bad prognosis do not usually present diagnostic delay 
whereas tumours with low proliferation rates elicit good prognosis despite long 
diagnostic delays (Seoane et al, 2010). Unfortunately, the evidence on tumour 
proliferation activity that could corroborate this hypothesis is scarce.
These results seem to suggest that the stage of oral cancer at the time of 
diagnosis is affected more by the biology of the cancer (degree of differentia-
tion) than by diagnostic delay.
The corroboration of the above mentioned theory implies that the ef-
forts aimed at early diagnosis of oral cancer should be prioritized towards 
screening programmes designed to detect the disease during its asymptom-
atic phase. Educational interventions on the population particularly focused 
on risk groups (self-exploration) and on the professionals (clinicians index of 
suspicion) should include a sound knowledge of the disease presentation, par-
ticularly on sites like the floor of the mouth, gingivae and retromolar trigone.
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10. CONClUSIONS
I. Advanced tumour stages in oral cancer have been conventionally as-
cribed to delays in reaching a diagnosis. Surprisingly, there is a lack of 
sound scientific evidence supporting this traditional association be-
tween diagnostic delay and disease extension and survival. However, 
different oral cancer genetic profiles result on a wide variability in the 
biological behavior of the tumour and may justify the hypothesis of the 
biological heterogeneity of diagnostic delay in oral cancer.
II. Diagnostic delay is a moderate risk factor of mortality from head and 
neck cancer. However, we cannot rule out that, at least, part of the effect 
observed may be due to residual confounding. We consider that new 
studies assessing the prognostic impact of diagnostic delay are neces-
sary. These studies should have a sound epidemiologic design with a 
prospective component in the follow-up in order to minimise recall 
bias. It is of paramount importance that optimal adjustment for con-
founding variables be carried out. These future investigations would 
also benefit from considering the biological features of the tumour and 
the delay in the treatment.
III. Male gender, intraoral locations other than lingual cancer, and a poor 
or moderate tumour differentiation behave as risk factors for late-stage 
diagnosis. These characteristics should be considered when designing 
educational interventions for the population, which should be particu-
larly focused on risk groups (self-exploration) and on the professionals 
(clinicians index of suspicion).
IV. The general dental practitioners attending oral cancer continuous 
medical education courses show positive preventive attitudes in the 
ambit of oral cancer, especially towards delivering counseling on alco-
hol consumption and performing routine esploration of the oral  mu-
cosa and biopsy.
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El cáncer de cabeza y cuello es la octava causa de muerte por cáncer en el 
mundo, y prácticamente la mitad de los pacientes son diagnosticados con en-
fermedades avanzadas. Estos estadios avanzados se asocian a altas tasas de 
mortalidad, con supervivencias a los 5 años que van del 82% para enferme-
dades localizadas al 27.6% en los casos con metástasis a distancia, sin que esta 
tasa de mortalidad haya sufridos variaciones sensibles en las últimas décadas. 
De hecho, aproximadamente un 19% de todos los pacientes diagnosticados 
de cáncer oral fallecen en durante el primer año, independientemente de los 
tratamientos a los que hayan sido sometidos. 
La relación entre el estadio en el momento del diagnóstico y la super-
vivencia concede a este parámetro un valor pronóstico intuitivo, corroborado 
por un ingente número de estudios que lo identifican como el más relevante 
de todas las variables implicadas en la supervivencia de estos pacientes. Sin 
embargo, es muy poco conocida la relación entre el retraso diagnóstico en 
cáncer oral y la extensión de la enfermedad diagnosticada en estadios avanza-
dos (TMN III-IV) y una tasa de supervivencia baja.
Es por esto, por lo que el diagnóstico precoz (Early detection) parece ser 
la piedra angular para reducir el retraso diagnóstico y mejorar la superviven-
cia al tumor. Sin embargo, este término es confuso y admite al menos un doble 
significado. De una parte, “precoz” informa sobre un pequeño tamaño tu-
moral en el momento de la detección y de otra “precoz” se refiere a un corto 
intervalo de tiempo para el diagnóstico.
Diagnóstico de Carcinomas Orales de pequeño tamaño.
El tamaño tumoral condiciona aspectos terapéuticos y pronósticos en el 
cáncer oral. Específicamente, el diagnóstico de carcinomas orales de tamaños 
grandes se asocia a un riesgo incrementado de metástasis en ganglios linfáti-
cos cervicales y pobre supervivencia. Más recientemente, se considera que el 
espesor tumoral o la profundidad de invasión constituye un factor pronóstico 
más relevante que el tamaño tumoral clínico o patológico. Además, esta vari-
able ha demostrado capacidad predictiva, de forma independiente, del riesgo 
de metástasis ganglionares subclínica, de recidivas locales y de supervivencia 
al tumor. En este sentido, se ha propuesto un espesor “crítico” de 4 mm, por 
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encima del cual, el riesgo de metástasis tumoral es cuatro veces mayor a los 
tumores con menor profundidad de invasión. En términos generales, se con-
sideran carcinomas orales de células escamosa (COCE) de pequeño tamaño 
a los menores de 2 cm. de diámetro, con menos de 4 mm de profundidad de 
invasión tumoral y generalmente asintomáticos. 
11.1.  Elaboración de una hipótesis biológica: El pronóstico del cáncer 
oral está más condicionado por el comportamiento biológico del 
tumor que por el retraso en el diagnóstico
Una revisión intensiva de la literatura nos ha permitido generar la hipótesis 
de la “Heterogeneidad biológica “ del tumor para explicar la variabilidad del 
retraso diagnóstico como factor pronóstico de la supervivencia al COCE. Esto 
es, la inconsistencia de la asociación entre un mayor retraso en el diagnóstico 
del cáncer oral y el peor resultado en términos de extensión de la enfermedad 
y de supervivencia. La diferente agresividad tumoral determinaría el estadiaje 
en el momento del diagnóstico y la supervivencia del paciente, en mayor me-
dida que la demora diagnóstica.
11.1.1. Bases de la hipótesis
Tumores de un mismo tipo de cáncer podrían tener una parecida agresividad 
clínica, sin embargo, diferentes carcinomas orales pueden presentar diferen-
tes tasas de crecimiento y diferentes niveles de agresividad. Recientemente 
nuestro grupo, en un estudio multivariante, ha demostrado que la actividad 
proliferativa, cuando se ajusta el análisis por estadios del tumor (I-II vs. III-
IV), resultó ser un factor pronóstico independiente para predecir la super-
vivencia . Sin embargo, el retraso diagnóstico no tuvo influencia significativa 
sobre esta variable. Estos resultados parecen sugerir que la supervivencia al 
cáncer oral se encuentra más afectada por el rápido crecimiento tumoral que 
por el retraso en el diagnóstico. 
El cáncer oral es un tumor relativamente agresivo que ha demostrado 
heterogeneidad en su comportamiento biológico; específicamente los carcino-
mas orales papilomavirus negativo (HPV -), aneuploides, y con TP53 mutado, 
han mostrado un pronóstico más desfavorable. Además, la expresión de dife-
rentes marcadores genéticos como el p16, p21, p27, MDM2, MgMT, EgFR, 
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ERBB2, RARB, MyC, BCR-ABL1, RAS, CCND1, STAT-3, VEgF, inducen un 
curso clínico más rápido de la enfermedad, lo que limita considerablemente 
el diagnóstico en estadios iniciales. Por el contrario, tumores HPV + de local-
ización predominantemente en orofaringe han mostrado un pronóstico mas 
favorable. 
11.1.2. ¿Como evaluar esta hipótesis?
Se ha sugerido que la biología del cáncer oral pudiese ser más decisiva en tér-
minos de supervivencia al tumor que el retraso diagnóstico. Con la finalidad 
de contrastar la veracidad de esta hipótesis parecen necesarios nuevos estu-
dios, con un adecuado diseño metodológico y que controle todos los sesgos 
detectados en estudios previos (selección, información, confusión, y super-
vivencia). Sería también indispensable utilizar criterios estandarizados para 
medir el retraso diagnóstico y desarrollar protocolos que intenten minimizar 
el sesgo de memoria. El empleo de cuestionarios estructurados en atención 
primaria y la colaboración de los familiares del paciente, también podría in-
crementar la calidad de los datos sobre el retraso diagnóstico.
Además, parecen recomendables estudios con un importante compo-
nente prospectivo, de base poblacional, con un adecuado tamaño muestral 
que tan solo considere casos incidentes de cáncer oral, y que tengan como 
principal resultado la supervivencia del paciente. También, deben ser con-
sideradas en el estudio otras variables pronósticas potencialmente confuso-
ras como la edad, el sexo, la localización, la comorbilidad y el tratamiento, 
incluyendo el retraso generado hasta el tratamiento, dado que podría tener 
un impacto potencial en el resultado final. Un punto clave para evaluar la 
heterogeneidad del cáncer oral y su potencialidad biológica radica en la fili-
ación histológica del tumor completo, en caso contrario podría generarse un 
sesgo asociado a la heterogeneidad del tumor, particularmente en tumores 
grandes. Estudios a desarrollar en el futuro podrían utilizar determinaciones 
cuantitativas del tipo de la citometría de flujo. Este procedimiento permite el 
estudio de la fracción de proliferación tumoral y de la apoptosis, lo que condi-
ciona la tasa de crecimiento tumoral. Además, el empleo de tecnología de “mi-
croarrays” ha demostrado la posibilidad de análisis de perfiles genéticos con 
importantes implicaciones clínicas y pueden ser utilizados para predecir el 
comportamiento clínico del cáncer oral y de esta manera ajustar el verdadero 
peso del retraso diagnóstico en la supervivencia del paciente.
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El diagnóstico de tumores de gran tamaño, o de enfermedad tumoral 
diseminada se ha asociado tradicionalmente al tiempo de retraso en alcanzar 
un diagnóstico definitivo. De forma sorprendente, parece existir una falta de 
evidencia que soporte esta asociación lógica entre retraso en el diagnóstico 
y la mayor extensión tumoral (peor supervivencia). De otra parte, diferen-
tes perfiles genéticos, ya conocidos, del cáncer oral condicionan una amplia 
variabilidad en el comportamiento biológico del tumor y podrían justificar la 
hipótesis de la heterogeneidad biología del retraso diagnóstico del cáncer oral. 
Un punto clave radica en la dificultad para comparar diferentes subtipos 
de cáncer oral con diferentes comportamientos biológicos. Así, tumores con 
tasas de crecimiento altas dificultarían el diagnóstico precoz, y el paciente dis-
pondría de un corto periodo temporal para un potencial “screening” tumor-
al, mientras tumores de crecimiento muy lento proporcionarían al paciente 
un amplio periodo para “screening” y en consecuencia intervenciones des-
tinadas a incrementar la proporción de tumores diagnosticados en estadios 
iniciales (TNM I-II) deberían considerar esta circunstancia. En este sentido, 
la asunción de la hipótesis implicaría favorecer estrategias de “screening” en 
cáncer y precáncer oral. Además, en base a este concepto debería fortalecerse 
el “screening” oportunista de esta patología en periodos asintomáticos, espe-
cíficamente en pacientes con factores de riesgo. 
11.2.  Estudio de los factores asociados al diagnóstico en estados 
avanzados de la enfermedad. 
Recientemente nuestro grupo ha demostrado mediante un estudio meta-
analítico que el retraso diagnóstico está ampliamente asociado a carcinomas 
orofaringeos diagnosticados en estadios avanzados de la enfermedad (TNM 
III-IV). Esta asociación se mostró especialmente fuerte cuando el análisis fue 
acotado a localizaciones orales del cáncer (pooled RR, 1.47; 95% CI, 1.09-
1.99) y cuando el retraso era mayor a un mes (pooled RR, 1.69; 95% CI, 1.26-
2.77). Sin embargo, estos datos deben manejarse cautelosamente debido a que 
los 9 estudios incluidos en este análisis fueron de carácter transversal, con dis-
eños retrospectivos y con un potencial sesgo de memoria. Además, una gran 
cantidad de estudios han evaluado los determinantes del retraso diagnóstico 
(periodo desde el primer síntoma o signo hasta conseguir el diagnóstico de-
finitivo), sin embargo son muy escasos los estudios enfocados a determinar 
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los predictores de diagnóstico en estadios avanzados, lo que está directamente 
implicado en la mortalidad por este tumor
Es por ello, por lo que el presente estudio se fijó como objetivo analizar 
los potenciales factores relacionados con el diagnóstico de la enfermedad en 
estadios avanzados (III-IV), con la finalidad de identificar grupos de riesgo y 
facilitar estrategias de detección precoz. Para ello llevamos a cabo un estudio 
ambispectivo, considerando una muestra de 88 pacientes con diagnóstico his-
tológico de cáncer oral procedentes del Servicio de Cirugía Maxilofacial del 
CHUAC que cumplían como criterio de inclusión en el estudio: El diagnósti-
co histológico de COCE (tumor primario) y cualquier localización anatómica 
oral (AJCS). Se consideraron las siguientes variables: la edad, el sexo, la local-
ización clínica, el consumo de tabaco y/o alcohol, el patrón macroscópico, la 
presencia de lesiones premalignas asociada al tumor, y el grado de diferen-
ciación tumoral. También se utilizaron estrategias encaminadas a minimizar 
el sesgo de memoria en la cuantificación del retraso diagnóstico. El estadio 
TNM fue considerado como variable dependiente (precoz: I o II; tardío = III 
o IV). Los datos se analizaron mediante un paquete estadístico SPSS 12.0 y se 
elaboró un modelo multivariante. El nivel de significación elegido para todas 
las pruebas fue p<0.05.
La edad media de la muestra fue de 60 años (DS=11.3), mayoritariamente 
varones (65.9%), fueron incluidos en el estudio. Las localizaciones preferentes 
fueron la lengua (36.4%), el suelo de boca (27.3%) y la encía (17% ).
La mediana del intervalo entre el primer signo/síntoma y el diagnóstico 
histológico ha sido de 45 días, no sufrieron retraso diagnóstico el 54.5% de la 
muestra y solo el 45.5% de los carcinomas orales se diagnosticaron en estadios 
precoces de la enfermedad (I-II). Las formas de presentación clínica más fre-
cuentes en el momento del diagnóstico han sido las ulceradas (70.5%) y en un 
16.5% de los casos el carcinoma oral se encontraba asociado a una lesión pre-
cancerosa. La muestra estaba constituida fundamentalmente por carcinomas 
bien y moderadamente diferenciados (91%). 
En el análisis univariante la edad (OR=1.0 ;CI95%=0.9-1.0), el hábi-
to tabáquico (OR=1.4 ;CI95%=0.5-3.9), la ingesta de alcohol (OR=1.0 
;CI95%=0.4-2.6 ), la co-existencia de lesión precancerosa (OR=0.6 
;CI95%=0.2-2.1) y la forma clínica de presentación (ulcerada/mixta) del car-
cinoma oral ( OR=2.7 ;CI95%=0.7-9.9) no se asociaron de forma significativa 
al diagnóstico en estados avanzados. Tampoco el retraso diagnóstico total se 
asoció al TNM-(III-IV) (OR=0.7 ;CI95%=0.3-1.6). Por el contrario, el sexo 
masculino se identificó como factor de riesgo de diagnóstico con enfermedad 
avanzada ( OR=3.8 ;CI95%=1.4-9.6). También en el análisis univariante los 
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tumores moderada/ pobremente diferenciados (OR=4.2 ;CI95%=1.6-10.9), 
con localizaciones en suelo de boca ( OR=3.6 ;CI95%=1.2-11.1), las encías ( 
OR=8.8 ;CI95%=2.0-38.2) y el trígono retromolar ( OR=8.8 ;CI95%=1.5-49.1) 
han mostrado una fuerte asociación con el diagnóstico en estadios avanzados 
de COCE. El análisis mediante regresión ha permitido excluir al sexo en el 
modelo multivariante permaneciendo como variables asociadas al riesgo de 
diagnóstico en estadios avanzados tanto la localización del tumor como el 
grado de diferenciación del mismo.
En la presente serie, hasta el 54.5% de los casos fueron diagnosticados en 
estadios avanzados. En este sentido, el conocimiento de predictores de diag-
nóstico en estadios avanzados permitiría el desarrollo de estrategias encami-
nadas a facilitar el diagnostico precoz.
La edad, el sexo, el consumo de tabaco y de alcohol no se han comportado 
como variables asociadas al diagnóstico tardío. Tampoco en estudios previos 
estas variables se han asociado de forma significativa al retraso diagnóstico 
asociado al paciente o al profesional. Las formas clínicas ulceradas del COCE 
han sido mayoritariamente diagnosticadas, hasta en el 60% de los casos, en 
estadios III-IV; sin embargo esta asociación no ha alcanzado significación es-
tadística. 
De otra parte, otros estudios han reflejado la existencia de asociación de 
localizaciones del carcinoma oral y retrasos diagnósticos ó diagnóstico en es-
tadios avanzados. La lengua, la mucosa bucal y el labio aparecen como local-
izaciones que favorecen el diagnostico en estadios iniciales de la enfermedad. 
Por el contrario, la localización de COCE en el suelo de boca y el trígono ret-
romolar facilitan los diagnósticos en estadios avanzados. Otras localizaciones 
como son el paladar o la encía han mostrado resultados contradictorios. En 
nuestro estudio, las localizaciones en suelo de boca, encia y trígono retromo-
lar se han comportado como un factor de riesgo independiente para el retraso 
diagnóstico. Estos hallazgos podrían explicarse por la diferente percepción 
del paciente y la dificultad de observación clínica en dependencia de la local-
ización tumoral.
La falta de consistencia que la literatura revela respecto a la asociación del 
retraso diagnóstico y la extensión tumoral, se encuentra probablemente oca-
sionada por problemas metodológicos, fundamentalmente relacionados con 
la heterogeneidad en la definición y el procedimiento de medida del retraso 
diagnóstico, la naturaleza retrospectiva de estos estudios y el sesgo de memo-
ria. En el presente estudio, el retraso en el diagnóstico no se asoció de forma 
significativa a tumores en estados avanzados. 
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Por el contrario, tumores pobremente diferenciados, biológicamente más 
agresivos, se comportaron como un factor de riesgo independiente para di-
agnósticos en estadios III-IV. En este sentido, el crecimiento tumoral podría 
actuar como un factor confusor de la relación retraso diagnóstico y enferme-
dad avanzada. Además, las medidas educativas dirigidas sobre la población, 
particularmente a los grupos de riesgo (autoexploración), y sobre los profe-
sionales para incrementar su grado de alerta en el diagnóstico del cáncer oral 
debe incluir información sobre los determinantes del diagnóstico tardío de la 
enfermedad. En esta línea, nuevos estudios deberían abordar aspectos de la 
biología tumoral en relación a la extensión de la enfermedad en el momento 
del diagnóstico.
11.3. Estudio del impacto del retraso en el diagnóstico sobre la super-
vivencia al cáncer oral
Diversos grupos de investigación han considerado criterios heterogéneos para 
definir el retraso diagnóstico en cáncer de cabeza y cuello, utilizando diferen-
tes fuentes de información y no han aportado en sus trabajos datos sobre las 
características genéticas o biológicas de la enfermedad. A pesar de ello, y de la 
falta de resultados homogéneos, algunos investigadores consideran al retraso 
diagnóstico como un factor pronóstico independiente para la supervivencia 
en los carcinomas de cabeza y cuello.
En vista a esta paradójica situación, nos planteamos llevar a cabo un me-
ta-análisis que permita evaluar el conocimiento existente sobre la potencial 
asociación del retraso en el diagnóstico y la supervivencia a este tipo de car-
cinomas
Se llevó a cabo una revisión sistemática con meta-análisis que incluyó las 
bases MEDLINE (1966-2010), EMBASE (1980-2011), y los “ISI proceedings” 
para artículos publicados en cualquier idioma. En la estrategia de búsque-
da se utilizaron los términos (“Head and neck cancers”) AND (“delay” OR 
“prognostic” OR “survival”).mp. [mp=title, abstract, subject headings, head-
ing word, drug trade name, original title, device manufacturer, drug manu-
facturer name]. Los estudios fueron considerados si cumplían los criterios de 
elegibilidad. 
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I. Proporcionar datos originales de pacientes con carcinomas con di-
agnóstico histológico, con estudios multivariantes y curvas de super-
vivencia con al menos 2 años de seguimiento. 
II. Que las muestras considerasen pacientes con carcinomas de cabeza y 
cuello (WHO-IARC), excluyendo tumores odontogénicos y de piel.
III. La exposición de interés fue el retraso en el diagnóstico, asignado a 
cualquiera de los agentes implicados. 
La calidad de los estudios se evaluó siguiendo las recomendaciones (MOOSE) 
para meta-análisis de estudios observacionales, y la cuantificación se llevó a 
cabo por 2 observadores independientes. Todos los análisis se hicieron medi-
ante el software HEPIMA, versión 2.1.3 .
Mediante esta estrategia de búsqueda se accedió a un total de 1016 artícu-
los, que fueron mayoritariamente excluidos en base a una pobre definición de 
la variable de exposición o por la ausencia de información de otras variables 
de interés. Finalmente, fueron seleccionados 8 artículos, uno de los cuales 
proporcionó de forma independiente datos sobre carcinomas orales, de far-
inge y de laringe. 
En términos generales, el riesgo relativo de mortalidad asociado al retra-
so diagnóstico en carcinomas de cabeza y cuello fue de 1.34 (1.12-1.61), con 
importante heterogeneidad (Ri=0.95). Cuando se estratificó el análisis atendi-
endo a los diferentes criterios de retraso diagnóstico, el retraso en la referencia 
del paciente mostró la mayor magnitud del efecto ( RR fixed effects =2.72 
(1.45-5.09)), mientras el retraso diagnóstico total mostró la menor magnitud 
en la asociación (RR fixed effects=1.04 ( 1.01-1.07). Los RR fueron 1.27 (0.81-
1.98) para el cáncer oral y de 1.64 (0.91-2.96) para el cáncer de laringe. 
Todos estos artículos reportan estudios de supervivencia de carácter ret-
rospectivo lo que podría generar una sobreestimación del efecto. Además, 
todos los trabajos habían ajustado el análisis multivariante por el estadio tu-
moral (TNM), sin embargo tan solo 2 estudios aportan datos sobre las carac-
terísticas biológicas de estos tumores. Cuando se consideraron los estudios de 
mayor calidad, estos proporcionaban un incremento del riesgo de mortalidad 
asociado al retraso en el diagnóstico en carcinomas de cabeza y cuello (RR= 
1.77 (1.14-2.75)). 
Entre las limitaciones de este estudio debemos advertir sobre la falta de 
consenso en la definición de retraso diagnóstico, la heterogeneidad de medi-
das que fueron utilizadas, la naturaleza retrospectiva de los estudios y el prob-
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able sesgo de memoria de los pacientes y de sus familiares. Este meta-análisis 
ha mostrado una sobreestimación del efecto en los estudios retrospectivos fr-
ente a los prospectivos ( RR (95%CI)=1.57 (1.11-2-24) vs. 1.04 ( 1.01-1.07)). 
De otra parte, la inclusión de artículos publicados en cualquier idioma 
parece prevenir la aparición de un potencial sesgo de lenguaje en el proceso 
de revisión e inclusión de estudios.
El grado de malignidad podría entenderse como un confusor potencial 
de la asociación; esto es, tumores con mayor agresividad presentan un peor 
pronostico y no suelen sufrir retraso diagnóstico. La contrapartida serían los 
tumores menos agresivos con mejor pronóstico y cuya indolencia suele acar-
rear retrasos hasta alcanzar el diagnóstico definitivo. 
Otra circunstancia que podría disturbar la asociación entre el retraso di-
agnóstico y la supervivencia es la influencia del retraso en el tratamiento. Esto 
ultimo muy dependiente del profesional y del sistema sanitario. 
En conclusión, el retraso diagnóstico se comporta como un factor de 
riesgo moderado en la mortalidad por cáncer de cabeza y cuello.
11.4. Educación continuada mediante artículos científicos: Actitudes 
preventivas de los dentistas generales respecto al cáncer oral.
Las estrategias educativas de control de cáncer son poco conocidas, sin em-
bargo, la educación médica continuada ha demostrado un alto impacto en las 
actitudes, el conocimiento y los comportamientos frente al cáncer oral.
En este sentido, la lectura de artículos científicos podría ser un compo-
nente clave en la educación médico-odontológica continuada.
Los dentistas juegan un papel fundamental en el diagnóstico precoz del 
cáncer oral. Diferentes autores han averiguado que entrenamientos específicos 
dirigidos a estudiantes de odontología y medicina pueden ser un componente 
crítico y efectivo dentro de las estrategias de control de cáncer. Estas estrate-
gias incluyen consejos para reducir el consumo de tabaco, la promoción de di-
etas saludables, y lo mas importante, la detección precoz mediante programas 
de screening oportunista con un adecuado seguimiento de los pacientes. En 
esta línea parece de radical importancia desarrollar iniciativas apropiadas para 
incrementar los conocimientos y favorecer actitudes preventivas tanto a nivel 
universitario como profesional usando la vía de la formación continuada.
El consejo general de odontólogos y estomatólogos de España ha lleva-
do a cabo recientemente una experiencia piloto en educación continuada en 
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cáncer oral por medio de la lectura de artículos científicos. El objetivo del es-
tudio fue evaluar las actitudes preventivas y clínicas relacionadas con el cáncer 
oral entre los dentistas españoles.
Para ello diseñamos un estudio transversal entre los dentistas generalistas 
con ejercicio en el territorio español que participaron en el programa online 
de educación continua en base a la revista RECOE (Revista del Consejo de 
Odontólogos y Estomatólogos de España), distribuida de forma gratuita entre 
los 25000 dentistas miembros del consejo general.
La población de estudio estuvo formada por 791 dentistas con una me-
dia de edad de 35 ± 9,6 años, mayoritariamente mujeres (61,7%), de los cu-
ales más de un tercio de ellos tenía más de 10 años de práctica profesional. 
En cerca de una cuarta parte de los participantes en el estudio, la lectura de 
artículos científicos de cáncer constituyó la única fuente de información sobre 
este tópico en el periodo de post-licenciatura.
La gran mayoría de los dentistas participantes proporcionan consejos 
sanitarios para abandonar el hábito tabáquico (96,6%), y dos tercios pro-
porcionan este tipo de consejos para reducir el consumo de alcohol. Por el 
contrario, solo el 42% recomiendan a sus pacientes el consumir una cantidad 
adecuada de frutas y verduras. La revisión sistematizada de la mucosa oral 
constituye una práctica clínica de rutina entre el 90,3% de los dentistas, pero 
solo el 29% realizan biopsias ante lesiones sospechosas orales. 
El análisis multivariante no permitió observar ninguna variable relacio-
nada con el proporcionar consejos sanitarios anti-tabaco, lo que significa que 
este tipo de consejos se proporcionan con independencia del grado de en-
trenamiento posgraduado de los dentistas. También pudo observarse que las 
recomendaciones sobre la ingesta de frutas y verduras, son proporcionadas 
más frecuentemente por los dentistas de mayor edad, sin que esta actitud pre-
ventiva haya podido relacionarse con la formación posgraduada.
Por el contrario la exploración rutinaria de la mucosa oral y el biopsiar 
lesiones sospechosas de malignidad han resultado ser actitudes preventivas 
relacionadas con la formación continuada. Los dentistas que han recibido cu-
atro o más cursos de formación continuada sobre cáncer oral tienen dos veces 
más probabilidad de proporcionar consejos sanitarios acerca del alcohol, diez 
veces más probabilidad de explorar sistemáticamente la mucosa, y 3,5 veces 
más probabilidad de tomar biopsias ante lesiones sospechosas. Finalmente, 
una larga experiencia profesional medida en términos de años de práctica 
clínica, no ha resultado estar relacionada con la probabilidad de adoptar me-
didas preventivas contra el cáncer oral.
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Estos resultados muestran que los cursos de formación continuada son 
útiles para incrementar las actitudes preven especialmente las relacionadas 
con la práctica clínica. Los cursos específicos parecen ser también útiles para 
incrementar la práctica de la biopsia oral. 
Sin embargo, estos hallazgos están limitados por el hecho de que derivan 
de un estudio transversal basado en una muestra de convergencia. Particular-
mente, la principal desventaja de este tipo de diseños, es que no permite una 
adecuada inferencia causal dado que las variables de exposición y de resulta-
dos son medidas al mismo tiempo, y la temporalidad no puede ser claramente 
establecida. Por otra parte, este tipo de estudios han demostrado su utilidad 
en el manejo de servicios médicos para mejorar la práctica clínica y para iden-
tificar problemas educacionales. 
Además, es necesario asumir un potencial sesgo de selección en nuestros 
datos, debido a la ausencia de randomización entre los participantes. En cu-
alquier caso, la población de nuestro estudio es representativa de la población 
de dentistas generalistas de España en lo que concierne a la edad, años de 
experiencia profesional, distribución geográfica y actitudes preventivas frente 
al cáncer oral.
Para proporcionar robustez a los riesgos relativos estimados hemos 
ajustado nuestros resultados por factores que podrían estar relacionados con 
el “outcome” del estudio y con las variables de exposición.
Sin duda la prevención ofrece la mejor estrategia en términos de coste-
efectividad para el control del cáncer.
A pesar de que los consejos sanitarios para la cesación tabáquica, el con-
sumo moderado de alcohol y dietas saludables son una parte esencial de la 
ética en el papel del dentista, diversas deficiencias en su conocimiento han 
podido ser identificadas en nuestro estudio, específicamente en aspectos edu-
cacionales y prácticas de prevención primaria y secundaria frente al cáncer 
oral. Nuestro estudio ha concluido que los dentistas generalistas que acuden 
a cursos de formación continuada específicos sobre cáncer oral muestran ac-
titudes preventivas positivas frente al mismo, específicamente en los consejos 
sanitarios para la cesación del consumo de alcohol, la exploración rutinaria de 
la mucosa oral y la biopsia.
La lectura de artículos científicos representa pues, un componente clave 
de la formación odontológica continuada. Además, la prevención del cáncer 
oral y su detección debería ser incluida periódicamente en las revistas den-
tales especializadas.
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DIAGNOSTIC DELAY
Sir, we have read with great interest the 
article by Dave,1 where the author warns 
about diagnostic delay in oral cancer and 
makes patients (patient delay), health-
care professionals (doctor delay) and the 
healthcare system (system delay) respon-
sible for it. The paper also highlights the 
importance of reducing delayed diagno-
sis in order to ensure cancer treatment at 
an early stage. However, when the ques-
tion ‘Why is reducing delayed diagnosis 
important?’ arises, the only answer in 
the manuscript is that ‘the most impor-
tant prognostic factor in oral cancer is 
the stage of the tumour at the time of 
diagnosis’, without considering that it 
has been proved that diagnostic delay is 
broadly associated with more advanced 
stage oral cancer (pooled RR: 1.47; 95% 
CI: 1.09-1.99), particularly when the 
delay is longer than one month (pooled 
RR: 1.69; 95% CI: 1.26-2.77).2 Moreover, 
the estimation of the relative risk of 
mortality for head and neck carcinomas 
related to any diagnostic delay (either 
patient or professional delay) is 1.34 (95% 
CI: 1.12-1.61), and specifically refer-
ral delay is associated with a three-fold 
increase in mortality.3 
Conversely, several research groups 
have studied the concept of delay in 
diagnosis of oral cancer but using hetero-
geneous criteria such as different types 
of data collected (eg continuous variables 
versus categorical), or diverse sources 
of information on patient delay (stand-
ard questionnaires, interviews, hospi-
tal records, etc) that may – along with 
variations in tumour biology - explain 
the absence of a consistent relation-
ship between diagnosis delay and stage 
at diagnosis in the literature. Despite 
these shortcomings, diagnostic delay has 
recently been related to a poorer survival 
rate in head and neck carcinomas.3
However, The Aarhus Statement has 
been proposed to improve the design 
and reporting of studies on early cancer 
diagnosis.4 This guideline recommends 
the substitution of the term ‘delay’ (eg 
‘patient delay’) for ‘intervals’ or ‘time 
intervals’. The aforementioned statement 
also suggests key time points (dates of 
first symptom; first presentation, refer-
ral and diagnosis) and time intervals.
Particularly relevant for GDPs are the 
date of first presentation and the date 
of referral. This time period could be 
shortened, as Dave accurately suggests, 
by using training as part of CPD for 
all members of the dental team, and a 
variety of additional approaches.
J. M. Seoane-Romero, P. Varela-Centelles, 
J. Seoane, Spain
1.  Dave B. Why do GDPs fail to recognise oral 
cancer? The argument for an oral cancer checklist. 
Br Dent J 2013; 214: 223–225.
2.  Gómez I, Seoane J, Varela-Centelles P, Diz P, Takk-
ouche B. Is diagnostic delay related to advanced-
stage oral cancer? A meta-analysis. Eur J Oral Sci 
2009; 117: 541–546.
3.  Seoane J, Takkouche B, Varela-Centelles P, Tomás I, 
Seoane-Romero J M. Impact of delay in diagnosis 
on survival to head and neck carcinomas: a 
systematic review with meta-analysis. Clin Otolar-
yngol 2012; 37: 99–106.
4.  Weller D, Vedsted P, Rubin G et al. The Aarhus 
statement: improving design and reporting of 
studies on early cancer diagnosis. Br J Cancer 
2012; 106: 1262–1267. 
DOI: 10.1038/sj.bdj.2013.587
WHITENING ADVOCATE
Sir, as most readers will be aware, the 
law regarding tooth whitening products 
containing more than 0.1% hydrogen 
peroxide changed on 1/10/12 making 
the use of such products illegal in any-
one under 18 years.
I had orthodontic treatment from an 
early age and the appearance of my 
teeth clearly improved, however, I was 
still extremely dissatisfied with opaci-
ties present on the central incisors. I 
would never smile exposing my teeth; 
I was extremely self-conscious and 
embarrassed if they were noticed. After 
talking to my dentist about this I was 
referred to the Charles Clifford Dental 
Hospital at 15 years of age. 
During the teenage years appear-
ance is crucially important. Secondary 
school can be a cruel place if you do 
not fit into the ‘norm’. Teenage years 
are a time of growth in confidence and 
of building self-esteem and the impact 
of the appearance of the teeth can be 
grossly underestimated unless you have 
experienced having a cosmetic defect.  
I was very fortunate in that the staff 
of the Paediatric Dentistry Depart-
ment, Charles Clifford Dental Hospi-
tal had a keen understanding of the 
personal impact on me. We discussed 
the possibility of tooth whitening and 
assessing the results before we seriously 
considered the more invasive treatment 
options. From my perspective, it was 
the ideal solution, being non-invasive 
with the potential for excellent results 
that could be easily maintained. I 
was able to undertake the whitening 
at home over a two-week period. The 
results were astonishing; the opacities 
were no longer visible and I encoun-
tered no side effects. The boost to my 
confidence cannot be underestimated. 
The results from the whitening treat-
ment definitely had the greatest positive 
impact out of all the treatment I’d had 
carried out over the years. 
I have recently undertaken another 
brief course of whitening treatment 
as the opacities were becoming visible 
again but this has resolved success-
fully after treatment. Now aged 20 and 
studying dentistry at Sheffield myself, 
I understand fully the impact that both 
cosmetic and pathological defects of the 
teeth have on an individual and this is 
partly the reason why I have chosen to 
train in the profession. 
I am a strong advocate of this treat-
ment in the type of circumstances I 
have described and find it difficult to 
believe that if I were in the same situ-
ation now it would not be possible to 
have this treatment. I cannot see any 
viable reason why a fully qualified 
dental professional could not carry out 
whitening treatment for patients with 
cosmetic defects that are clearly affect-
ing their mental wellbeing.  
A. Coulby
By email
DOI: 10.1038/sj.bdj.2013.588
LONG IN THE TOOTH TECHNIQUE
Sir, with reference to osteo-odonto 
keratoprosthesis (Tooth in eye surgery; 
BDJ 2013; 214: 373), this technique 
was reported in this journal as long 
ago as 1966.1 
606 BRITISH DENTAL JOURNAL  VOLUME 214  NO. 12  JUN 22 2013 
LETTERS
© 2013 Macmillan Publishers Limited. All rights reserved

